CN111233898A - Organic small molecule conjugated material containing isotactic bipyridine thiadiazole receptor and preparation method and application thereof - Google Patents
Organic small molecule conjugated material containing isotactic bipyridine thiadiazole receptor and preparation method and application thereof Download PDFInfo
- Publication number
- CN111233898A CN111233898A CN202010158042.3A CN202010158042A CN111233898A CN 111233898 A CN111233898 A CN 111233898A CN 202010158042 A CN202010158042 A CN 202010158042A CN 111233898 A CN111233898 A CN 111233898A
- Authority
- CN
- China
- Prior art keywords
- formula
- thiadiazole
- small molecule
- bipyridine
- isotactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 116
- 150000003384 small molecules Chemical class 0.000 title claims abstract description 95
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims abstract description 71
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- 238000006619 Stille reaction Methods 0.000 claims abstract description 9
- BFJMHTOBRRZELQ-UHFFFAOYSA-N 3-iodo-2h-pyrazolo[3,4-c]pyridine Chemical compound N1=CC=C2C(I)=NNC2=C1 BFJMHTOBRRZELQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 102
- 239000000543 intermediate Substances 0.000 claims description 94
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 86
- -1 n-octyl Chemical group 0.000 claims description 66
- 239000000047 product Substances 0.000 claims description 63
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 58
- 239000002904 solvent Substances 0.000 claims description 47
- 229910052757 nitrogen Inorganic materials 0.000 claims description 44
- 239000000243 solution Substances 0.000 claims description 38
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 29
- 229910052763 palladium Inorganic materials 0.000 claims description 29
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 26
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 25
- 239000012074 organic phase Substances 0.000 claims description 25
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000003054 catalyst Substances 0.000 claims description 22
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- 239000004065 semiconductor Substances 0.000 claims description 19
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 17
- 239000012043 crude product Substances 0.000 claims description 14
- 239000010408 film Substances 0.000 claims description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 12
- 229930192474 thiophene Natural products 0.000 claims description 12
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 11
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 11
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000010898 silica gel chromatography Methods 0.000 claims description 10
- UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Natural products C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 claims description 8
- 150000001716 carbazoles Chemical class 0.000 claims description 8
- 239000010409 thin film Substances 0.000 claims description 8
- GCTFWCDSFPMHHS-UHFFFAOYSA-M Tributyltin chloride Chemical compound CCCC[Sn](Cl)(CCCC)CCCC GCTFWCDSFPMHHS-UHFFFAOYSA-M 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- PJRGCJBBXGNEGD-UHFFFAOYSA-N 2-bromo-9h-carbazole Chemical compound C1=CC=C2C3=CC=C(Br)C=C3NC2=C1 PJRGCJBBXGNEGD-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 150000001491 aromatic compounds Chemical class 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 230000005669 field effect Effects 0.000 claims description 6
- 235000011056 potassium acetate Nutrition 0.000 claims description 6
- 238000009987 spinning Methods 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 claims description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 229940117389 dichlorobenzene Drugs 0.000 claims description 3
- 238000004528 spin coating Methods 0.000 claims description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims description 2
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 229910003002 lithium salt Inorganic materials 0.000 claims description 2
- 159000000002 lithium salts Chemical class 0.000 claims description 2
- OKCBEPHXQAIBDY-UHFFFAOYSA-N lithium;thiophene Chemical compound [Li].C=1C=CSC=1 OKCBEPHXQAIBDY-UHFFFAOYSA-N 0.000 claims description 2
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 6
- UXQXGDFZRHINFF-UHFFFAOYSA-N S1C=CC=C1.C(CCC)[Sn] Chemical compound S1C=CC=C1.C(CCC)[Sn] UXQXGDFZRHINFF-UHFFFAOYSA-N 0.000 claims 3
- UNXISIRQWPTTSN-UHFFFAOYSA-N boron;2,3-dimethylbutane-2,3-diol Chemical compound [B].[B].CC(C)(O)C(C)(C)O UNXISIRQWPTTSN-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229920006395 saturated elastomer Chemical class 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 claims 1
- 229960001701 chloroform Drugs 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 16
- 230000005693 optoelectronics Effects 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 230000005611 electricity Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000031700 light absorption Effects 0.000 abstract description 2
- 239000000370 acceptor Substances 0.000 description 79
- 238000001228 spectrum Methods 0.000 description 22
- 238000005481 NMR spectroscopy Methods 0.000 description 21
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 17
- 239000007787 solid Substances 0.000 description 11
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 9
- 238000000862 absorption spectrum Methods 0.000 description 9
- 239000003480 eluent Substances 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 9
- 230000008033 biological extinction Effects 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 230000037230 mobility Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- BMIBJCFFZPYJHF-UHFFFAOYSA-N 2-methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine Chemical compound COC1=NC=C(C)C=C1B1OC(C)(C)C(C)(C)O1 BMIBJCFFZPYJHF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000021615 conjugation Effects 0.000 description 4
- 238000002484 cyclic voltammetry Methods 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000000584 ultraviolet--visible--near infrared spectrum Methods 0.000 description 3
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000004770 highest occupied molecular orbital Methods 0.000 description 2
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- IVDFJHOHABJVEH-UHFFFAOYSA-N pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 description 2
- AKYFJADNRLTBGV-UHFFFAOYSA-N pyridine;thiadiazole Chemical compound C1=CSN=N1.C1=CC=NC=C1 AKYFJADNRLTBGV-UHFFFAOYSA-N 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- SLMOIPABFJZKOU-UHFFFAOYSA-N tributyl-(5-butylthiophen-2-yl)stannane Chemical compound C(CCC)C=1SC(=CC=1)[Sn](CCCC)(CCCC)CCCC SLMOIPABFJZKOU-UHFFFAOYSA-N 0.000 description 2
- YHLNBSBPGDDXDT-UHFFFAOYSA-N 2-bromo-9-(2-decyltetradecyl)carbazole Chemical compound BrC1=CC=2N(C3=CC=CC=C3C=2C=C1)CC(CCCCCCCCCCCC)CCCCCCCCCC YHLNBSBPGDDXDT-UHFFFAOYSA-N 0.000 description 1
- MNDZHERKKXUTOE-UHFFFAOYSA-N 2-butylthiophene Chemical compound CCCCC1=CC=CS1 MNDZHERKKXUTOE-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- CLWRFNUKIFTVHQ-UHFFFAOYSA-N [N].C1=CC=NC=C1 Chemical group [N].C1=CC=NC=C1 CLWRFNUKIFTVHQ-UHFFFAOYSA-N 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000013086 organic photovoltaic Methods 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920002848 poly(3-alkoxythiophenes) Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- PIILXFBHQILWPS-UHFFFAOYSA-N tributyltin Chemical compound CCCC[Sn](CCCC)CCCC PIILXFBHQILWPS-UHFFFAOYSA-N 0.000 description 1
- WIOADUFWOUUQCV-UHFFFAOYSA-N triphenylphosphanium dichloride Chemical compound [Cl-].[Cl-].C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 WIOADUFWOUUQCV-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/655—Aromatic compounds comprising a hetero atom comprising only sulfur as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
- C09K2211/1066—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
本发明公开了一种含等规双吡啶噻二唑受体的有机小分子共轭材料及其制备方法与应用,该有机小分子共轭材料具有以下式(I)、式(II)或式(III)所示的结构式。本发明首次以7‑溴‑4‑氯[1,2,5]噻二唑[3,4‑c]吡啶为原料,采用Stille偶联等反应合成了含等规双吡啶噻二唑受体的有机小分子共轭材料,并提供了一种调控双吡啶噻二唑基有机小分子共轭材料的结构规整性和光电性能的技术方案。该类有机小分子共轭材料具有吸电能力强、骨架共轭大、溶解性良好、热稳定性优异以及吸光能力强等优点,制备方法简单高效、重复性好和普适性高,可推广开发更多结构规整型D‑A型有机共轭材料,在有机光电领域具有商业前景。 The invention discloses an organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor and a preparation method and application thereof. The organic small molecule conjugated material has the following formula (I), formula (II) or formula The structural formula shown in (III). The present invention uses 7-bromo-4-chloro[1,2,5]thiadiazole[3,4-c]pyridine as raw material for the first time, and adopts Stille coupling and other reactions to synthesize isotactic bipyridine thiadiazole receptors The organic small molecule conjugated material is provided, and a technical scheme for regulating the structural regularity and optoelectronic properties of the bipyridine thiadiazole-based organic small molecule conjugated material is provided. This type of organic small molecule conjugated material has the advantages of strong electricity absorption ability, large skeleton conjugate, good solubility, excellent thermal stability and strong light absorption ability. The preparation method is simple and efficient, with good repeatability and high universality, and can be promoted The development of more structured D-A-type organic conjugated materials has commercial prospects in the field of organic optoelectronics.
Description
技术领域technical field
本发明属于有机光电功能材料领域,涉及用于有机场效应晶体管器件的有机小分子共轭材料及其结构规整性调控方法与应用,具体涉及一种含等规双吡啶噻二唑受体的有机小分子共轭材料及其制备方法与应用。The invention belongs to the field of organic optoelectronic functional materials, relates to an organic small molecule conjugated material used for organic field effect transistor devices and a method for regulating the regularity of its structure and its application, in particular to an organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor. Small molecule conjugated material and preparation method and application thereof.
背景技术Background technique
相对于结构无规的有机共轭材料,结构规整型有机共轭材料具有更有序的主链骨架结构、更突出的薄膜组装能力、更宽的薄膜吸收以及更高的载流子迁移率等优势。近年来,有机共轭材料的结构规整性控制及其在有机电子学领域的应用得到广泛关注。早期的研究发现:通过控制3-烷基噻吩进入聚合物主链的序列结构,科学家开发出了具有严格头尾(H-T)相连的聚(3-烷基噻吩),并发现其薄膜组装能力、结晶度、吸收光谱、载流子迁移率以及光伏性能都得到了显著提升(J.Am.Chem.Soc.,1992,114,10087–10088;Nature.,1999,401,685–688;Nat.Mater.,2006,5,197–203)。最近,结构规整性控制理念进一步推广用于设计D-A型有机小分子和聚合物共轭材料。譬如,化学家将结构不对称的吡啶噻二唑受体单元引入到D-A型有机/聚合物半导体材料的主链中,通过调控受体单元中吡啶N原子在主链上的取向,开发了一系列综合性能优异、结构规整的D-A型有机/聚合物半导体材料(J.Am.Chem.Soc.,2011,133,18538–18541;Chem.Commun.,2013,49,7192–7194;J.Am.Chem.Soc.,2014,136,12576–12579;J.Am.Chem.Soc.,2017,139,17735–17738)。尽管吡啶噻二唑受体单元被广泛应用于合成高性能的有机/聚合物半导体材料,但含等规双吡啶噻二唑受体的D-A型有机小分子共轭材料及其结构规整性控制方法依然未见报道,开发该类有机共轭材料并探讨结构规整性与光电性能之间的关系具有重要的意义。Compared with random organic conjugated materials, structurally regular organic conjugated materials have more ordered main chain skeleton structure, more prominent film assembly ability, wider film absorption and higher carrier mobility, etc. Advantage. In recent years, the control of structural regularity of organic conjugated materials and their applications in the field of organic electronics has received extensive attention. Earlier research found that by controlling the sequential structure of 3-alkylthiophenes into the polymer backbone, scientists developed poly(3-alkylthiophenes) with strict head-to-tail (H-T) linkages and discovered their ability to assemble thin films, Crystallinity, absorption spectrum, carrier mobility, and photovoltaic performance have all been significantly improved (J.Am.Chem.Soc., 1992, 114, 10087–10088; Nature., 1999, 401, 685–688; Nat.Mater. , 2006, 5, 197–203). Recently, the idea of structural regularity control has been further generalized for the design of D-A-type organic small molecules and polymer conjugated materials. For example, chemists introduced structurally asymmetric pyridinethiadiazole acceptor units into the main chain of D-A-type organic/polymer semiconductor materials, and developed a A series of D-A organic/polymer semiconductor materials with excellent comprehensive properties and regular structure (J.Am.Chem.Soc., 2011, 133, 18538–18541; Chem. Commun., 2013, 49, 7192–7194; J.Am Chem. Soc., 2014, 136, 12576-12579; J. Am. Chem. Soc., 2017, 139, 17735-17738). Although pyridinethiadiazole acceptor units are widely used in the synthesis of high-performance organic/polymer semiconductor materials, D-A-type organic small molecule conjugated materials containing isotactic bipyridinethiadiazole acceptors and their structural regularity control methods There is still no report, it is of great significance to develop such organic conjugated materials and explore the relationship between structural regularity and optoelectronic properties.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一类含等规双吡啶噻二唑受体的有机小分子共轭材料及其制备方法与应用。本发明解决的技术问题在于提供了一种合成系列含等规双吡啶噻二唑受体单元的有机小分子共轭材料的规整性调控方法,用于研究分子结构与其性能之间的关系。The purpose of the present invention is to provide a class of organic small molecule conjugated materials containing isotactic bipyridine thiadiazole acceptors, and a preparation method and application thereof. The technical problem solved by the present invention is to provide a regularity regulation method for synthesizing a series of organic small molecule conjugated materials containing isotactic bipyridine thiadiazole acceptor units, for studying the relationship between molecular structure and its properties.
一种含等规双吡啶噻二唑受体的有机小分子共轭材料,所述含等规双吡啶噻二唑受体的有机小分子共轭材料具有以下式(I)、式(II)或式(III)所示的结构式:An organic small molecule conjugated material containing an isotactic bipyridyl thiadiazole acceptor, the organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor has the following formulas (I) and (II) Or the structural formula shown in formula (III):
所述式(I)、式(II)或式(III)中,Ar为式(IV)或式(V)所示结构式中的一种,In the formula (I), formula (II) or formula (III), Ar is one of the structural formulas shown in formula (IV) or formula (V),
所述式(IV)或式(V)中,R1选自C4-C16的直链烷基,R2选自C8-C30支链烷基。In the formula (IV) or formula (V), R 1 is selected from a C 4 -C 16 straight chain alkyl group, and R 2 is selected from a C 8 -C 30 branched chain alkyl group.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料,优选的,所述R1为正丁基、正戊基、正己基、正庚基、正辛基、正壬基、正癸基、正十一烷基、正十二烷基、正十三烷基、正十四烷基、正十五烷基或正十六烷基;所述R2为2-乙基己基、2-丁基己基、2-己基辛基、4-己基癸基、3-己基十一烷基、2-辛基癸基、2-辛基十二烷基、3-辛基十三烷基、2-癸基十二烷基、2-癸基十四烷基、3-癸基十五烷基、2-十二烷基十六烷基、4-辛基十四烷基、4-癸基十六烷基、4-己基癸基、4-辛基十二烷基、4-癸基十四烷基或4-十二烷基十六烷基。Above-mentioned organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, described R 1 is n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl , n-decyl, n-undecyl, n-dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl or n-hexadecyl; the R 2 is 2-ethyl Hexyl, 2-butylhexyl, 2-hexyloctyl, 4-hexyldecyl, 3-hexylundecyl, 2-octyldecyl, 2-octyldodecyl, 3-octyltridecyl Alkyl, 2-decyldodecyl, 2-decyltetradecyl, 3-decylpentadecyl, 2-dodecylhexadecyl, 4-octyltetradecyl, 4-decylhexadecyl, 4-hexyldecyl, 4-octyldodecyl, 4-decyltetradecyl or 4-dodecylhexadecyl.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料,优选的,所述含等规双吡啶噻二唑受体的有机小分子共轭材料为M1、M2、M3、M4、M5或M6,分别对应以下式VI、式VII、式VIII、式IX、式X和式XI所示的结构式:The above-mentioned organic small molecule conjugated materials containing isotactic bipyridyl thiadiazole acceptors, preferably, the organic small molecule conjugated materials containing isotactic bipyridine thiadiazole acceptors are M1, M2, M3, M4 , M5 or M6, respectively corresponding to the structural formula shown in the following formula VI, formula VII, formula VIII, formula IX, formula X and formula XI:
作为一个总的发明构思,本发明还提供一种上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,包括如下步骤:As a general inventive concept, the present invention also provides a method for preparing the above-mentioned isotactic bipyridine thiadiazole acceptor-containing organic small molecule conjugated material, comprising the following steps:
(1)在氮气保护下,用丁基锂将芳香化合物中间体Ar转换成锂盐,然后加入三丁基氯化锡,得到三丁基锡烷基芳香化合物中间体式(XII):(1) Under nitrogen protection, the aromatic compound intermediate Ar is converted into a lithium salt with butyllithium, and then tributyltin chloride is added to obtain the tributyltin alkyl aromatic compound intermediate formula (XII):
所述式(XII)中,Ar为式(IV)或式(V)所示结构式中的一种;In the formula (XII), Ar is one of the structural formulas shown in formula (IV) or formula (V);
其中,所述R1和R2的定义与上述产品中R1和R2的定义相同。Wherein, the definitions of R 1 and R 2 are the same as the definitions of R 1 and R 2 in the above-mentioned products.
(2)在氮气保护下,将三丁基锡烷基芳香化合物中间体式(XII)与7-溴-4-氯[1,2,5]噻二唑[3,4-c]吡啶进行钯催化Stille偶联反应,得到中间体a和b;(2) Under nitrogen protection, tributylstannyl aromatic compound intermediate formula (XII) and 7-bromo-4-chloro[1,2,5]thiadiazo[3,4-c]pyridine were subjected to palladium-catalyzed Stille Coupling reaction to obtain intermediates a and b;
所述中间体a的结构式为:The structural formula of the intermediate a is:
所述中间体b的结构式为:The structural formula of the intermediate b is:
所述式a或b中,Ar为式(IV)或式(V)所示结构式中的一种;In described formula a or b, Ar is a kind of in the structural formula shown in formula (IV) or formula (V);
其中,所述R1和R2的定义与产品中R1和R2的定义相同;Wherein, the definitions of described R 1 and R 2 are the same as the definitions of R 1 and R 2 in the product;
(3)制备式(I):在氮气保护下,将中间体a与联硼酸频那醇酯在钯催化下发生Suzuki偶联反应,得到吡啶N原子同时朝向外侧的目标产物式(I),(3) preparation formula (I): under nitrogen protection, Suzuki coupling reaction occurs with intermediate a and biboronic acid pinacol ester under palladium catalysis, obtains the target product formula (I) of pyridine N atom towards the outside simultaneously,
所述式(I)中,Ar为式(IV)或式(V)所示结构中的一种;In the formula (I), Ar is one of the structures represented by the formula (IV) or the formula (V);
其中,所述R1和R2的定义与产品中R1和R2的定义相同。Wherein, the definitions of R 1 and R 2 are the same as the definitions of R 1 and R 2 in the product.
或者,制备式(II):在氮气保护下,将中间体b与1,1,1,2,2,2-六甲基二锡在钯催化下发生Stille偶联反应,得到吡啶N原子同时朝向内侧的目标产物式(II),Alternatively, to prepare formula (II): under the protection of nitrogen, a Stille coupling reaction between intermediate b and 1,1,1,2,2,2-hexamethylditin is catalyzed by palladium to obtain a pyridine N atom at the same time towards the inner target product formula (II),
所述式(II)中,Ar为式(IV)或式(V)所示结构中的一种;In the formula (II), Ar is one of the structures represented by the formula (IV) or the formula (V);
其中,所述R1和R2的定义与产品中R1和R2的定义相同。Wherein, the definitions of R 1 and R 2 are the same as the definitions of R 1 and R 2 in the product.
或者,制备式(III):在氮气保护下,将中间体b先与1,1,1,2,2,2-六甲基二锡在钯催化下先反应1小时,然后再一次性加入中间体a,继续发生Stille偶联反应,得到吡啶N原子同时朝向同侧的目标产物式(III),Or, to prepare formula (III): under nitrogen protection, the intermediate b is first reacted with 1,1,1,2,2,2-hexamethylditin under palladium catalysis for 1 hour, and then added at one time Intermediate a, continue to undergo Stille coupling reaction to obtain the target product formula (III) with the pyridine N atom facing the same side at the same time,
所述式(III)中,Ar为式(IV)或式(V)所示结构中的一种;In the formula (III), Ar is one of the structures shown in the formula (IV) or the formula (V);
其中,所述R1和R2的定义与产品中R1和R2的定义相同。Wherein, the definitions of R 1 and R 2 are the same as the definitions of R 1 and R 2 in the product.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述步骤(1)具体为:氮气保护下,将芳香化合物中间体(Ar)和溶剂混合,-78℃下加入正丁基锂,反应0.5小时~2小时,再加入三丁基氯化锡,在室温下反应5小时~30小时,二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,得到式XII所示三丁基锡烷基芳香中间体。所述芳香化合物中间体(Ar)、正丁基锂与三丁基氯化锡的投料摩尔比为1.0:1.0~1.3:1.0~1.3。The above-mentioned preparation method of the organic small molecule conjugated material containing the isotactic bipyridine thiadiazole acceptor, preferably, the step (1) is specifically: under nitrogen protection, the aromatic compound intermediate (Ar) is mixed with a solvent , at -78 ℃, add n-butyllithium, react for 0.5 hours to 2 hours, then add tributyltin chloride, react at room temperature for 5 hours to 30 hours, extract with dichloromethane and saturated brine, separate the organic phase, After drying over anhydrous magnesium sulfate, after filtration, the solvent is removed by spinning to obtain the tributylstannyl aromatic intermediate represented by formula XII. The molar ratio of the aromatic compound intermediate (Ar), n-butyllithium and tributyltin chloride is 1.0:1.0-1.3:1.0-1.3.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述步骤(2)具体为:在氮气保护下,将式(XII)所示的三丁基锡烷基芳香化合物中间体、7-溴-4-氯[1,2,5]噻二唑[3,4-c]吡啶、钯催化剂和溶剂混合,在70~150℃搅拌反应5~24个小时,二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,同时得到中间体化合物a和中间体化合物b,所述式(XII)所示的中间体、7-溴-4-氯[1,2,5]噻二唑[3,4-c]吡啶与钯催化剂的投料摩尔比为1.0:1.0~1.5:0.005~0.2。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the step (2) is specifically: under nitrogen protection, the tributyltin shown in formula (XII) Alkyl aromatic compound intermediate, 7-bromo-4-chloro[1,2,5]thiadiazole[3,4-c]pyridine, palladium catalyst and solvent are mixed, and stirred at 70~150℃ for 5~24 reactions h, extract with dichloromethane and saturated brine, separate the organic phase, dry over anhydrous magnesium sulfate, filter, and spin to remove the solvent to simultaneously obtain intermediate compound a and intermediate compound b, the intermediate compound shown in the formula (XII). The molar ratio of 7-bromo-4-chloro[1,2,5]thiadiazole[3,4-c]pyridine to the palladium catalyst is 1.0:1.0-1.5:0.005-0.2.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述步骤(3)中式(I)的制备具体为:氮气保护下,将中间体a、联硼酸频那醇酯、醋酸钾、钯催化剂和溶剂混合,在70~150℃搅拌反应5~24个小时,待混合物溶液冷却至室温后,二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,粗产物经硅胶柱层析纯化,得到吡啶N原子同时朝向外侧的目标产物式(I),所述中间体a、联硼酸频那醇酯、醋酸钾与钯催化剂的投料摩尔比为1.0:1.0~2.0:1.0~3.0:0.005~0.2。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the preparation of formula (I) in the step (3) is specifically: under nitrogen protection, intermediate a, Biboronate pinacol ester, potassium acetate, palladium catalyst and solvent are mixed, and the reaction is stirred at 70 to 150 ° C for 5 to 24 hours. After the mixture solution is cooled to room temperature, it is extracted with dichloromethane and saturated brine, and the organic phase is separated. Dry over anhydrous magnesium sulfate, after filtration, spin to remove the solvent, and the crude product is purified by silica gel column chromatography to obtain the target product formula (I) with the pyridine N atom facing the outside at the same time, the intermediate a, pinacol biboronate, The molar ratio of potassium acetate to palladium catalyst is 1.0:1.0-2.0:1.0-3.0:0.005-0.2.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述步骤(3)中式(II)的制备具体为:氮气保护下,将中间体b、1,1,1,2,2,2-六甲基二锡、钯催化剂和溶剂混合,在70~150℃搅拌反应10~24个小时,待混合物溶液冷却至室温后,采用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,粗产物经硅胶柱层析纯化,得到吡啶N原子同时朝向外侧的目标产物式(II),所述中间体b、1,1,1,2,2,2-六甲基二锡与钯催化剂的投料摩尔比为1.0:0.4~1.0:0.01~0.2。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the preparation of formula (II) in the step (3) is specifically: under nitrogen protection, intermediate b, 1,1,1,2,2,2-Hexamethylditin, palladium catalyst and solvent are mixed, and the reaction is stirred at 70 to 150 ° C for 10 to 24 hours. After the mixture solution is cooled to room temperature, dichloromethane and Saturated brine extraction, separation of the organic phase, drying over anhydrous magnesium sulfate, after filtration, the solvent was removed by spinning, and the crude product was purified by silica gel column chromatography to obtain the target product formula (II) with the pyridine N atom facing the outside, the intermediate b. The molar ratio of 1,1,1,2,2,2-hexamethylditin to the palladium catalyst is 1.0:0.4-1.0:0.01-0.2.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述步骤(3)中式(III)的制备具体为:氮气保护下,将中间体b、钯催化剂、1,1,1,2,2,2-六甲基二锡和溶剂混合,在70~150℃下搅拌反应0.5小时~2小时后,一次性加入中间体a,继续在70~150℃下搅拌反应3小时~24个小时,待混合物溶液冷却至室温后,采用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,粗产物经硅胶柱层析纯化,得到吡啶N原子同时朝向同侧的目标产物式(III),所述中间体b、中间体a、1,1,1,2,2,2-六甲基二锡与钯催化剂的投料摩尔比为1.0:1.0:0.8~1.6:0.01~0.2。The above-mentioned preparation method of the organic small molecule conjugated material containing the isotactic bipyridine thiadiazole acceptor, preferably, the preparation of the formula (III) in the step (3) is specifically: under nitrogen protection, intermediate b, Palladium catalyst, 1,1,1,2,2,2-hexamethylditin and solvent are mixed, and the reaction is stirred at 70~150℃ for 0.5 hour~2 hours, then intermediate a is added at one time, and the temperature is continued at 70~150℃. The reaction was stirred at 150°C for 3 to 24 hours. After the mixture solution was cooled to room temperature, it was extracted with dichloromethane and saturated brine, the organic phase was separated, dried over anhydrous magnesium sulfate, filtered, and the solvent was removed. Silica gel column chromatography was purified to obtain the target product formula (III) with the pyridine N atom facing the same side at the same time. The intermediate b, intermediate a, 1,1,1,2,2,2-hexamethylditin and The molar ratio of the palladium catalyst is 1.0:1.0:0.8-1.6:0.01-0.2.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述式(IV)主要由以下方法制备得到:在氮气保护下,用丁基锂将噻吩转换成噻吩锂盐,然后加入1-溴代烷烃,得到式(IV)所示2-烷基噻吩中间体。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the formula (IV) is mainly prepared by the following method: under the protection of nitrogen, thiophene is treated with butyllithium It is converted into thiophene lithium salt and then added with 1-bromoalkane to obtain the 2-alkylthiophene intermediate represented by formula (IV).
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述式(V)主要由以下方法制备得到:The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the formula (V) is mainly prepared by the following method:
(S1)在氮气保护下,采用亲核取代方法,将2-溴咔唑与1-溴代烷烃反应,得到2-溴-9-烷基取代咔唑中间体c;(S1) under nitrogen protection, adopt nucleophilic substitution method to react 2-bromocarbazole with 1-bromoalkane to obtain 2-bromo-9-alkyl-substituted carbazole intermediate c;
所述中间体c的结构式为:The structural formula of the intermediate c is:
其中,所述R2的定义与产品中R2的定义相同;Wherein, the definition of described R 2 is the same as the definition of R 2 in the product;
(S2)在氮气保护下,采用Stille偶联反应,将中间体c与噻吩丁基锡试剂反应,得到式(V)所示结构中的任意一种。(S2) Under nitrogen protection, using Stille coupling reaction, intermediate c is reacted with thiophenebutyltin reagent to obtain any one of the structures represented by formula (V).
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述式(IV)的制备过程具体为:氮气保护下,将噻吩和溶剂混合,-78℃下加入正丁基锂,反应1.5~2个小时,再加入1-溴代烷烃,反应过夜,采用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,得到式(IV)所示2-烷基噻吩中间体;所述噻吩、正丁基锂与1-溴代烷烃的投料摩尔比为1.0:1.0~1.3:1.0~1.3。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the preparation process of the formula (IV) is specifically: under nitrogen protection, mix thiophene and solvent, -78 Add n-butyllithium at ℃, react for 1.5 to 2 hours, then add 1-bromoalkane, react overnight, extract with dichloromethane and saturated brine, separate the organic phase, dry over anhydrous magnesium sulfate, filter, spin The solvent is removed to obtain the 2-alkylthiophene intermediate represented by formula (IV); the molar ratio of the thiophene, n-butyllithium and 1-bromoalkane is 1.0:1.0-1.3:1.0-1.3.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述式(V)的制备过程中,所述(S1)具体为:氮气保护下,将2-溴咔唑、1-溴代烷烃、氢化钠和溶剂混合,在50~150℃搅拌反应5~24个小时,采用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,得到2-溴-9-烷基取代咔唑中间体c;所述2-溴咔唑、1-溴代烷烃与氢化钠的投料摩尔比为1.0:1.0~3.0:1.0~3.0;The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, in the preparation process of the formula (V), the (S1) is specifically: under nitrogen protection, the 2-Bromocarbazole, 1-bromoalkane, sodium hydride and solvent are mixed, stirred and reacted at 50~150℃ for 5~24 hours, extracted with dichloromethane and saturated brine, separated organic phase, dried over anhydrous magnesium sulfate , after filtration, the solvent is removed by spinning to obtain 2-bromo-9-alkyl-substituted carbazole intermediate c; the molar ratio of the 2-bromocarbazole, 1-bromoalkane and sodium hydride is 1.0:1.0~3.0 : 1.0~3.0;
所述(S2)具体为:在氮气保护下,将2-溴-9-烷基取代咔唑中间体c、噻吩丁基锡试剂、钯催化剂和溶剂混合,在70~150℃搅拌反应5~24个小时,采用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,过滤后,旋除溶剂,得到式(V)所示结构中的任意一种化合物;所述2-溴-9-烷基取代咔唑中间体c、噻吩丁基锡试剂与钯催化剂的投料摩尔比为1.0:1.0~3.0:0.01~0.2。The (S2) is specifically: under nitrogen protection, mixing 2-bromo-9-alkyl-substituted carbazole intermediate c, thiophenebutyltin reagent, palladium catalyst and solvent, and stirring at 70-150° C. for 5-24 reactions h, extracted with dichloromethane and saturated brine, separated the organic phase, dried over anhydrous magnesium sulfate, filtered, and removed the solvent to obtain any compound in the structure shown in formula (V); the 2-bromo- The molar ratio of the 9-alkyl-substituted carbazole intermediate c, the thiophenebutyltin reagent and the palladium catalyst is 1.0:1.0-3.0:0.01-0.2.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述钯催化剂选自四(三苯基膦)钯、双(三苯基膦)二氯化钯、醋酸钯、三(二亚苄基丙酮)二钯中的至少一种。The preparation method of the above-mentioned organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptors, preferably, the palladium catalyst is selected from tetrakis (triphenylphosphine) palladium, bis (triphenylphosphine) dichloride at least one of palladium, palladium acetate and tris(dibenzylideneacetone)dipalladium.
上述的含等规双吡啶噻二唑受体的有机小分子共轭材料的制备方法,优选的,所述溶剂选自甲苯、二甲苯、三甲苯、N,N′-二甲基甲酰胺、N,N′-二甲基乙酰胺、N-甲基吡咯烷酮、氯苯、二氯苯、三氯苯、1,4-二氧六环、四氢呋喃、乙腈和1,4-二氧六环中的至少一种。The above-mentioned preparation method of the organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor, preferably, the solvent is selected from toluene, xylene, trimethylbenzene, N,N'-dimethylformamide, N,N'-dimethylacetamide, N-methylpyrrolidone, chlorobenzene, dichlorobenzene, trichlorobenzene, 1,4-dioxane, tetrahydrofuran, acetonitrile and 1,4-dioxane at least one of.
作为一个总的发明构思,本发明还提供一种上述的含等规双吡啶噻二唑受体的有机小分子共轭材料或者上述的制备方法制得的含等规双吡啶噻二唑受体的有机小分子共轭材料在制备有机薄膜场效应晶体管器件中的应用。As a general inventive concept, the present invention also provides the above-mentioned isotactic bipyridylthiadiazole acceptor-containing organic small molecule conjugated material or the above-mentioned preparation method containing isotactic bipyridinethiadiazole acceptor. The application of organic small molecule conjugated materials in the preparation of organic thin film field effect transistor devices.
上述的应用,优选的,所述应用方法为:首先,将含等规双吡啶噻二唑受体的有机小分子共轭材料溶于三氯甲烷溶液中,将所得溶液旋涂在玻璃衬底表面获得一层有机半导体活性层薄膜;其次,在所述有机半导体活性层薄膜表面旋涂聚甲基丙烯酸甲酯的醋酸丁酯溶液获得聚甲基丙烯酸甲酯介电层;最后,在所述聚甲基丙烯酸甲酯介电层上蒸镀一层铝做为栅电极。For the above application, preferably, the application method is: first, the organic small molecule conjugated material containing the isotactic bipyridine thiadiazole acceptor is dissolved in a chloroform solution, and the obtained solution is spin-coated on a glass substrate A layer of organic semiconductor active layer film is obtained on the surface; secondly, a butyl acetate solution of polymethyl methacrylate is spin-coated on the surface of the organic semiconductor active layer film to obtain a polymethyl methacrylate dielectric layer; finally, a polymethyl methacrylate dielectric layer is obtained on the surface of the organic semiconductor active layer film A layer of aluminum is evaporated on the polymethyl methacrylate dielectric layer as a gate electrode.
本发明提供了含等规双吡啶噻二唑受体的有机小分子共轭材料,旨在调控双吡啶噻二唑受体上吡啶N原子的朝向,得到三种异构体,研究分子结构的差异对其光电性能的影响。其主要设计思路如下:1)相比单一吡啶噻二唑电子受体,双吡啶噻二唑电子受体具有更强的缺电能力,将其引入到有机小分子共轭材料的骨架中,可提高目标分子的电子亲和力以及调控材料的能级和光谱吸收。因而,克服了单吡啶噻二唑受体单元吸电能力弱和骨架共轭小的缺点;2)通过控制吡啶噻二唑上吡啶N的相对位置,可得到吡啶N朝向不同的三种含等规双吡啶噻二唑受体的有机小分子共轭材料的异构体,便于调控材料的光电性能;3)改变末端取代端基,通过引入给电性较强、共平面性较好的咔唑基团,可增强分子的共轭程度,便于调控材料的光电性能。The invention provides an organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor, aiming to regulate the orientation of the pyridine N atom on the bipyridyl thiadiazole acceptor, obtain three isomers, and study the molecular structure of the material. The effect of the difference on its optoelectronic properties. The main design ideas are as follows: 1) Compared with the single pyridinethiadiazole electron acceptor, the bipyridylthiadiazole electron acceptor has stronger power-deficient ability. Improve the electron affinity of the target molecule and tune the energy level and spectral absorption of the material. Therefore, it overcomes the shortcomings of weak charge-absorbing ability and small skeleton conjugation of the monopyridine thiadiazole acceptor unit; 2) By controlling the relative position of pyridine N on pyridine thiadiazole, three different orientations of pyridine N can be obtained. The isomer of the organic small molecule conjugated material of the regular bipyridine thiadiazole acceptor is easy to control the optoelectronic properties of the material; 3) By changing the terminal substitution end group, by introducing carboxylate with strong charge-donating property and good coplanarity The azole group can enhance the degree of conjugation of the molecule and facilitate the adjustment of the optoelectronic properties of the material.
与现有技术相比,本发明的优点在于:Compared with the prior art, the advantages of the present invention are:
1、本发明的合成技术路线具有简单高效、原料易得、成本低廉以及普适性强等优点。适用于放大合成与批量制备,可以推广开发具有吸电能力强、骨架共轭大、溶解性良好、热稳定性优异以及吸光能力强的等规双受体型有机共轭材料。1. The synthetic technical route of the present invention has the advantages of simplicity and high efficiency, readily available raw materials, low cost and strong universality. It is suitable for scale-up synthesis and batch preparation, and can be popularized and developed for isotactic double-acceptor organic conjugated materials with strong electricity absorption ability, large skeleton conjugation, good solubility, excellent thermal stability and strong light absorption ability.
2、本发明的该类目标有机共轭小分子材料具有骨架共轭大和杂原子含量高的优点,因而提高了分子间的组装能力。2. The target organic conjugated small molecule material of the present invention has the advantages of large skeleton conjugation and high content of heteroatoms, thus improving the intermolecular assembly ability.
3、本发明的该类目标有机共轭小分子材料中含有强缺电能力的双吡啶噻二唑受体单元以及强给电能力的噻吩/咔唑衍生物给体单元,增强分子内的电荷转移作用,因而拓宽了材料的吸收光谱和荧光光谱。3. The target organic conjugated small molecule material of the present invention contains a bipyridine thiadiazole acceptor unit with strong electricity-deficient ability and a thiophene/carbazole derivative donor unit with strong electricity-donating ability to enhance the charge in the molecule transfer, thus broadening the absorption and fluorescence spectra of the material.
4、通过精准控制吡啶噻二唑上吡啶N的朝向,开发出了三种含等规双吡啶噻二唑受体的有机小分子共轭材料,成功调控了材料的光电性能。4. By precisely controlling the orientation of pyridine N on pyridinethiadiazole, three kinds of organic small molecule conjugated materials containing isotactic bipyridinethiadiazole acceptors were developed, and the optoelectronic properties of the materials were successfully regulated.
5、本发明提供了一种含等规双吡啶噻二唑受体的有机小分子共轭材料的应用,所示有机小分子共轭材料M4用于有机薄膜场效应晶体管器件中,获得了高达0.05cm2/V s的空穴迁移率,充分显示了该类有机小分子共轭材料在有机场效应晶体管、有机光伏、有机光探测器以及生物荧光成像等领域中的商业应用前景。5. The present invention provides the application of an organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor, and the organic small molecule conjugated material M4 is used in an organic thin film field effect transistor device, and obtains up to The hole mobility of 0.05 cm 2 /V s fully demonstrates the commercial application prospects of this type of organic small molecule conjugated materials in the fields of organic field effect transistors, organic photovoltaics, organic photodetectors, and bioluminescence imaging.
附图说明Description of drawings
图1为实施例1中含等规双吡啶噻二唑受体的有机小分子共轭材料M1的混合时间为0.3s的1H-1H NOE谱图。FIG. 1 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M1 containing an isotactic bipyridine thiadiazole acceptor in Example 1 with a mixing time of 0.3 s.
图2为实施例1中含等规双吡啶噻二唑受体的有机小分子共轭材料M1的混合时间为0.8s的1H-1H NOE谱图。FIG. 2 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M1 containing an isotactic bipyridine thiadiazole acceptor in Example 1 with a mixing time of 0.8 s.
图3为实施例2中含等规双吡啶噻二唑受体的有机小分子共轭材料M2的混合时间为0.3s的1H-1H NOE谱图。FIG. 3 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M2 containing an isotactic bipyridine thiadiazole acceptor in Example 2 with a mixing time of 0.3 s.
图4为实施例2中含等规双吡啶噻二唑受体的有机小分子共轭材料M2的混合时间为0.8s的1H-1H NOE谱图。4 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M2 containing isotactic bipyridine thiadiazole acceptors in Example 2 with a mixing time of 0.8 s.
图5为实施例3中含等规双吡啶噻二唑受体的有机小分子共轭材料M3的混合时间为0.3s的1H-1H NOE谱图。5 is the 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M3 containing the isotactic bipyridine thiadiazole acceptor in Example 3 when the mixing time is 0.3 s.
图6为实施例3中含等规双吡啶噻二唑受体的有机小分子共轭材料M3的混合时间为0.8s的1H-1H NOE谱图。6 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M3 containing an isotactic bipyridine thiadiazole acceptor in Example 3 with a mixing time of 0.8 s.
图7为实施例4中含等规双吡啶噻二唑受体的有机小分子共轭材料M4的混合时间为0.3s的1H-1H NOE谱图。FIG. 7 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor in Example 4 with a mixing time of 0.3 s.
图8为实施例4中含等规双吡啶噻二唑受体的有机小分子共轭材料M4的混合时间为0.8s的1H-1H NOE谱图。8 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M4 containing isotactic bipyridine thiadiazole acceptors in Example 4 with a mixing time of 0.8 s.
图9为实施例5中含等规双吡啶噻二唑受体的有机小分子共轭材料M5的混合时间为0.3s的1H-1H NOE谱图。9 is a 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M5 containing an isotactic bipyridine thiadiazole acceptor in Example 5 with a mixing time of 0.3 s.
图10为实施例5中含等规双吡啶噻二唑受体的有机小分子共轭材料M5的混合时间为0.8s的1H-1H NOE谱图。10 is the 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M5 containing the isotactic bipyridine thiadiazole acceptor in Example 5 when the mixing time is 0.8 s.
图11为实施例6中含等规双吡啶噻二唑受体的有机小分子共轭材料M6的混合时间为0.3s的1H-1H NOE谱图。11 is the 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M6 containing the isotactic bipyridine thiadiazole acceptor in Example 6 when the mixing time is 0.3 s.
图12为实施例6中含等规双吡啶噻二唑受体的有机小分子共轭材料M6的混合时间为0.8s的1H-1H NOE谱图。12 is the 1 H- 1 H NOE spectrum of the organic small molecule conjugated material M6 containing isotactic bipyridine thiadiazole acceptors in Example 6 with a mixing time of 0.8 s.
图13为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M1、M2和M3在氯仿溶液状态下的紫外–可见–近红外吸收光谱。Figure 13 shows the ultraviolet-visible-near-infrared absorption spectra of three organic small molecule conjugated materials M1, M2 and M3 containing isotactic bipyridine thiadiazole acceptors in chloroform solution.
图14为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M1、M2和M3在薄膜状态下的紫外–可见–近红外吸收光谱。Figure 14 shows the ultraviolet-visible-near-infrared absorption spectra of three organic small molecule conjugated materials M1, M2 and M3 containing isotactic bipyridine thiadiazole acceptors in the thin film state.
图15为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M4、M5和M6在氯仿溶液状态下的紫外–可见–近红外吸收光谱。Figure 15 shows the ultraviolet-visible-near-infrared absorption spectra of three organic small molecule conjugated materials M4, M5 and M6 containing isotactic bipyridine thiadiazole acceptors in chloroform solution.
图16为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M4、M5和M6在薄膜状态下的紫外–可见–近红外吸收光谱。Figure 16 shows the ultraviolet-visible-near-infrared absorption spectra of three organic small molecule conjugated materials M4, M5 and M6 containing isotactic bipyridine thiadiazole acceptors in the thin film state.
图17为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M1、M2和M3的摩尔消光系数谱图。Figure 17 is the molar extinction coefficient spectra of three organic small molecule conjugated materials M1, M2 and M3 containing isotactic bipyridine thiadiazole acceptors.
图18为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M4、M5和M6的摩尔消光系数谱图。Figure 18 is the molar extinction coefficient spectra of three organic small molecule conjugated materials M4, M5 and M6 containing isotactic bipyridine thiadiazole acceptors.
图19为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M1、M2和M3在氯仿溶液状态下的荧光光谱图。Fig. 19 is the fluorescence spectra of three organic small molecule conjugated materials M1, M2 and M3 containing isotactic bipyridine thiadiazole acceptors in the state of chloroform solution.
图20为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M4、M5和M6在氯仿溶液状态下的荧光光谱图。Figure 20 is the fluorescence spectra of three organic small molecule conjugated materials M4, M5 and M6 containing isotactic bipyridine thiadiazole acceptors in the state of chloroform solution.
图21为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M1、M2和M3在氯仿溶液中测定的循环伏安曲线。Figure 21 shows the cyclic voltammetry curves of three organic small molecule conjugated materials M1, M2 and M3 containing isotactic bipyridine thiadiazole acceptors measured in chloroform solution.
图22为三种含等规双吡啶噻二唑受体的有机小分子共轭材料M4、M5和M6在氯仿溶液中测定的循环伏安曲线。Figure 22 shows the cyclic voltammetry curves of three organic small molecule conjugated materials M4, M5 and M6 containing isotactic bipyridine thiadiazole acceptors measured in chloroform solution.
图23为本发明实施例4中以含等规双吡啶噻二唑受体的有机小分子共轭材料M4为有机活性半导体层的FET器件结构示意图。23 is a schematic structural diagram of a FET device using an organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor as an organic active semiconductor layer in Example 4 of the present invention.
图24为本发明实施例4中以含等规双吡啶噻二唑受体的有机小分子共轭材料M4为有机活性半导体层的FET器件的输出特性曲线图。24 is an output characteristic curve diagram of a FET device using the organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor as the organic active semiconductor layer in Example 4 of the present invention.
图25为本发明实施例4中以含等规双吡啶噻二唑受体的有机小分子共轭材料M4为有机活性半导体层的FET器件的转移特性曲线图。FIG. 25 is a transfer characteristic curve diagram of a FET device using an organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor as an organic active semiconductor layer in Example 4 of the present invention.
具体实施方式Detailed ways
以下结合说明书附图和具体优选的实施例对本发明作进一步描述,但并不因此而限制本发明的保护范围。以下所述实施例旨在便于对本发明的理解,而对其不起任何限定作用。所述方法如无特别说明均为常规方法。所述反应物料如无特别说明均能从公开商业途径购买而得。The present invention will be further described below with reference to the accompanying drawings and specific preferred embodiments, but the protection scope of the present invention is not limited thereby. The examples described below are intended to facilitate the understanding of the present invention without any limitation thereto. The methods are conventional methods unless otherwise specified. The reaction materials can be purchased from open commercial sources unless otherwise specified.
实施例1:Example 1:
一种本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记为M1,具有式(I)所式的结构通式:An organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor of the present invention, denoted as M1, has the general structural formula of formula (I):
其中,Ar为R1为正丁基。Among them, Ar is R 1 is n-butyl.
M1具体的结构式为:The specific structural formula of M1 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M1的合成路线为:A synthetic route of the organic small molecule conjugated material M1 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
具体包括以下步骤:Specifically include the following steps:
(1)2-丁基噻吩的合成:参考文献(J.Am.Chem.Soc.2006,128,2336)报道的方法合成;(1) Synthesis of 2-butylthiophene: synthesis by the method reported in the reference (J.Am.Chem.Soc.2006,128,2336);
(2)2-三丁基锡烷基-5-丁基噻吩的合成:参考文献(Org.Lett.2008,10,3665)报道的方法合成;(2) Synthesis of 2-tributylstannyl-5-butylthiophene: synthesis by the method reported in the reference (Org.Lett.2008,10,3665);
(3)中间体a和b的合成:在氮气保护下,向两口瓶中加入600mg的7-溴-4-氯-[1,2,5]噻二唑-[3,4-c]吡啶(2.4mmol)、1.095g的2-三丁基锡烷基-5-丁基噻吩(2.4mmol)、双(三苯基膦)二氯化钯(0.03mmol)和15mL的甲苯溶剂。105℃下搅拌8小时后,冷却至室温。有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=4︰1,V︰V),得322mg黄色固体即中间体a(收率=38%),223mg橙色固体即中间体b(收率=30%)。(3) Synthesis of intermediates a and b: under nitrogen protection, add 600 mg of 7-bromo-4-chloro-[1,2,5]thiadiazole-[3,4-c]pyridine to a two-necked flask (2.4 mmol), 1.095 g of 2-tributylstannyl-5-butylthiophene (2.4 mmol), bis(triphenylphosphine)palladium dichloride (0.03 mmol) and 15 mL of toluene solvent. After stirring at 105°C for 8 hours, it was cooled to room temperature. The organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel column (eluent: petroleum ether: dichloromethane = 4: 1, V: V) to obtain 322 mg of yellow solid, intermediate a (yield = 38%), 223 mg of orange solid, intermediate b ( Yield = 30%).
结构表征数据如下:The structural representation data is as follows:
中间体a:1H NMR(400MHz,CDCl3),δ(ppm):8.61(s,1H),8.50(d,1H),6.94(d,1H),2.90(t,2H),1.77–1.73(m,2H),1.44(dd,2H),0.96(t,3H).13C NMR(100MHz,CDCl3),δ(ppm):156.26,153.12,147.86,147.57,145.78,138.15,133.14,126.58,107.48,33.47,30.26,22.18,13.82.HRMS:m/z[M]+calcd for(C13H12BrN3S2):352.9656;found:352.9652.Intermediate a: 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 8.61 (s, 1H), 8.50 (d, 1H), 6.94 (d, 1H), 2.90 (t, 2H), 1.77-1.73 (m, 2H), 1.44 (dd, 2H), 0.96 (t, 3H). 13 C NMR (100 MHz, CDCl 3 ), δ (ppm): 156.26, 153.12, 147.86, 147.57, 145.78, 138.15, 133.14, 126.58 , 107.48, 33.47, 30.26, 22.18, 13.82. HRMS: m/z[M] + calcd for(C 13 H 12 BrN 3 S 2 ): 352.9656; found: 352.9652.
由上可知,该化合物结构正确,为所示中间体a。From the above, it can be seen that the structure of this compound is correct, and it is shown as intermediate a.
中间体b:1H NMR(400MHz,CDCl3),δ(ppm):8.57(s,1H),7.94(d,1H),6.91(d,1H),2.90(t,2H),1.76–1.72(m,2H),1.45(dd,2H),0.97(t,3H).13C NMR(100MHz,CDCl3),δ(ppm):154.83,149.52,148.79,142.64,138.90,132.35,129.02,125.58,122.69,33.66,29.98,22.21,13.82.HRMS:m/z[M]+calcd for(C13H12ClN3S2):309.0161;found:309.0162.Intermediate b: 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 8.57 (s, 1H), 7.94 (d, 1H), 6.91 (d, 1H), 2.90 (t, 2H), 1.76-1.72 (m, 2H), 1.45 (dd, 2H), 0.97 (t, 3H). 13 C NMR (100 MHz, CDCl 3 ), δ (ppm): 154.83, 149.52, 148.79, 142.64, 138.90, 132.35, 129.02, 125.58 , 122.69, 33.66, 29.98, 22.21, 13.82. HRMS: m/z[M] + calcd for(C 13 H 12 ClN 3 S 2 ): 309.0161; found: 309.0162.
由上可知,该化合物结构正确,为所示中间体b。From the above, it can be seen that the structure of this compound is correct, and it is shown as intermediate b.
(4)目标产物M1的合成:在氮气保护下,向两口瓶中加入500mg的中间体a(1.4mmol)、358.5mg的联硼酸频那醇酯(1.4mmol)、412.5mg的醋酸钾(4.2mmol)、双(三苯基膦)二氯化钯(0.01mmol)和20mL的1,4-二氧六环溶剂。80℃下搅拌8个小时后,有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=4︰1,V︰V),得到329mg暗红色固体即目标产物M1(收率=85%)。(4) Synthesis of target product M1: under nitrogen protection, add 500 mg of intermediate a (1.4 mmol), 358.5 mg of biboronic acid pinacol ester (1.4 mmol), 412.5 mg of potassium acetate (4.2 mmol) to the two-necked flask mmol), bis(triphenylphosphine)palladium dichloride (0.01 mmol) and 20 mL of 1,4-dioxane solvent. After stirring at 80°C for 8 hours, the organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel chromatography (eluent: petroleum ether:dichloromethane=4:1, V:V) to obtain 329 mg of dark red solid, the target product M1 (yield=85%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.37(s,2H),8.60(d,2H),6.98(d,2H),2.94(t,4H),1.80–1.76(m,4H),1.49–1.46(m,4H),1.00–0.96(t,6H).13C NMR(100MHz,CDCl3),δ(ppm):156.10,153.03,148.10,148.01,145.87,139.04,133.12,126.55,119.54,33.52,30.31,22.24,13.85.HRMS:m/z[M]+calcd for(C26H24N6S4):549.1018;found:549.1018. 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 9.37 (s, 2H), 8.60 (d, 2H), 6.98 (d, 2H), 2.94 (t, 4H), 1.80–1.76 (m, 4H) ), 1.49–1.46 (m, 4H), 1.00–0.96 (t, 6H). 13 C NMR (100MHz, CDCl 3 ), δ (ppm): 156.10, 153.03, 148.10, 148.01, 145.87, 139.04, 133.12, 126.55 , 119.54, 33.52, 30.31, 22.24, 13.85. HRMS: m/z[M] + calcd for(C 26 H 24 N 6 S 4 ): 549.1018; found: 549.1018.
由上可知,该化合物结构正确,为所示目标产物M1。It can be seen from the above that the structure of this compound is correct, and it is the target product M1 shown.
实施例2:Example 2:
一种本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记作M2,具有式(II)的结构通式:An organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptors of the present invention, denoted as M2, has the general structural formula of formula (II):
其中,Ar为R1为正丁基。Among them, Ar is R 1 is n-butyl.
M2具体的结构式为:The specific structural formula of M2 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M2的合成路线为:A synthetic route of the organic small molecule conjugated material M2 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
步骤(1)、(2)、(3)的合成方法同实施例1。The synthetic methods of steps (1), (2) and (3) are the same as in Example 1.
(4)目标产物M2的合成:在氮气保护下,向两口瓶中加入200mg的中间体b(0.65mmol)、141mg的1,1,1,2,2,2-六甲基二锡(0.43mmol)、双(三苯基膦)二氯化钯(0.06mmol)和7mL的甲苯溶剂。110℃下搅拌15小时后,有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=1︰1,V︰V),得66mg橙色固体即目标产物M2(收率=37%)。(4) Synthesis of target product M2: under nitrogen protection, 200 mg of intermediate b (0.65 mmol) and 141 mg of 1,1,1,2,2,2-hexamethylditin (0.43 mg) were added to the two-necked flask. mmol), bis(triphenylphosphine)palladium dichloride (0.06 mmol) and 7 mL of toluene solvent. After stirring at 110°C for 15 hours, the organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel chromatography (eluent: petroleum ether: dichloromethane=1:1, V:V) to obtain 66 mg of orange solid, the target product M2 (yield=37%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.16(s,2H),8.12(d,2H),6.96(d,2H),2.94(t,4H),1.80–1.76(m,4H),1.47(dd,4H),0.99(t,6H).13C NMR(100MHz,CDCl3),δ(ppm):155.04,150.32,150.06,147.69,139.84,133.46,129.70,125.79,123.46,33.69,30.10,22.27,13.84.HRMS:m/z[M]+calcd for(C26H24N6S4):549.1018;found:549.1019. 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 9.16 (s, 2H), 8.12 (d, 2H), 6.96 (d, 2H), 2.94 (t, 4H), 1.80–1.76 (m, 4H) ), 1.47(dd, 4H), 0.99(t, 6H). 13 C NMR (100MHz, CDCl 3 ), δ(ppm): 155.04, 150.32, 150.06, 147.69, 139.84, 133.46, 129.70, 125.79, 123.46, 33.69 , 30.10, 22.27, 13.84. HRMS: m/z[M] + calcd for(C 26 H 24 N 6 S 4 ): 549.1018; found: 549.1019.
由上可知,该化合物结构正确,为所示目标产物M2。From the above, it can be seen that the structure of this compound is correct, and it is the target product M2 shown.
实施例3:Example 3:
一种本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记为M3,具有式(III)的结构通式:An organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor of the present invention, denoted as M3, has the general structural formula of formula (III):
其中,Ar为R1为正丁基。Among them, Ar is R 1 is n-butyl.
M3具体的结构式为:The specific structural formula of M3 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M3的合成路线为:A synthetic route of the organic small molecule conjugated material M3 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
步骤(1)、(2)、(3)的合成方法同实施例1。The synthetic methods of steps (1), (2) and (3) are the same as in Example 1.
(4)目标产物M3的合成:在氮气保护下,向两口瓶中加入200mg的中间体b(0.56mmol)、246mg的1,1,1,2,2,2-六甲基二锡和(0.75mmol)、双(三苯基膦)二氯化钯(0.03mmol)和8mL的甲苯溶剂,在110℃下搅拌1小时后,再一次性加入174mg中间体a(0.56mmol),继续在110℃下搅拌24小时后,有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=1︰1,V︰V),得130mg橙红色固体即目标产物M3(收率=42%)。(4) Synthesis of target product M3: under nitrogen protection, 200 mg of intermediate b (0.56 mmol), 246 mg of 1,1,1,2,2,2-hexamethyldistin and ( 0.75 mmol), bis(triphenylphosphine) palladium dichloride (0.03 mmol) and 8 mL of toluene solvent, and after stirring at 110 ° C for 1 hour, 174 mg of intermediate a (0.56 mmol) was added at one time, and continued at 110 After stirring at °C for 24 hours, the organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel column (eluent: petroleum ether: dichloromethane = 1: 1, V: V) to obtain 130 mg of orange-red solid, the target product M3 (yield = 42%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.49(s,1H),9.13(s,1H),8.68(d,1H),8.06(d,1H),7.01(d,1H),6.95(d,1H),2.94(q,4H),1.78(d,4H),1.47(dd,4H),0.98(td,6H).13CNMR(100MHz,CDCl3),δ(ppm):155.97,154.76,153.95,150.13,149.57,149.28,148.44,147.69,147.45,140.38,139.03,133.91,133.54,129.02,126.77,125.61,122.11,121.64,33.69,33.53,30.36,30.07,22.29,22.23,13.95,13.84.HRMS:m/z[M]+calcd for(C26H24N6S4):549.1018;found:549.1019. 1 H NMR (400MHz, CDCl 3 ), δ(ppm): 9.49(s,1H), 9.13(s,1H), 8.68(d,1H), 8.06(d,1H), 7.01(d,1H), 6.95 (d, 1H), 2.94 (q, 4H), 1.78 (d, 4H), 1.47 (dd, 4H), 0.98 (td, 6H). 13 CNMR (100 MHz, CDCl 3 ), δ (ppm): 155.97 ,154.76,153.95,150.13,149.57,149.28,148.44,147.69,147.45,140.38,139.03,133.91,133.54,129.02,126.77,125.61,122.11,121.64,33.69,33.53,30.36,30.07,22.29,22.23,13.95,13.84 .HRMS: m/z[M] + calcd for (C 26 H 24 N 6 S 4 ): 549.1018; found: 549.1019.
由上可知,该化合物结构正确,为所示目标产物M3。It can be seen from the above that the structure of this compound is correct, and it is the target product M3 shown.
实施例4:Example 4:
一种本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记为M4,具有式(I)的结构通式:An organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptors of the present invention, denoted as M4, has the general structural formula of formula (I):
其中,Ar为R2为2-癸基十四烷基。Among them, Ar is R 2 is 2-decyltetradecyl.
M4具体的结构式为:The specific structural formula of M4 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M4的合成路线为:A synthetic route of the organic small molecule conjugated material M4 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
具体包括以下步骤:Specifically include the following steps:
(1)化合物c的合成:参考文献(New J.Chem.2018,42,2750)报道的方法合成;(1) Synthesis of compound c: synthesized by the method reported in the reference (New J.Chem.2018, 42, 2750);
(2)化合物d的合成:在氮气保护下,向两口瓶中加入5.3g的2-溴-9-(2-癸基十四烷基)咔唑(9.1mmol)、3.78g的2-三丁基锡基-噻吩(9.1mmol)、双(三苯基膦)二氯化钯(0.06mmol)和15mL的甲苯溶剂。105℃下搅拌8小时后,冷却至室温。有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚)得4.1g白色固体即中间体d(收率=77%)。(2) Synthesis of compound d: under nitrogen protection, 5.3g of 2-bromo-9-(2-decyltetradecyl)carbazole (9.1mmol), 3.78g of 2-tris Butyltinyl-thiophene (9.1 mmol), bis(triphenylphosphine)palladium dichloride (0.06 mmol) and 15 mL of toluene solvent. After stirring at 105°C for 8 hours, it was cooled to room temperature. The organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel column (eluent is petroleum ether) to obtain 4.1 g of white solid, intermediate d (yield=77%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):8.07(dd,2H),7.59(s,1H),7.50(dd,1H),7.45(t,1H),7.40–7.37(m,2H),7.30–7.29(m,1H),7.22(t,1H),7.12(dd,1H),4.18(d,2H),2.15(s,1H),1.38–1.21(m,40H),0.88(dd,6H).13C NMR(100MHz,CDCl3),δ(ppm):145.79,141.52,141.32,131.95,128.05,125.66,124.47,122.90,122.61,122.31,120.61,120.25,118.96,117.44,109.03,106.28,47.62,37.92,31.94,31.92,29.98,29.69,29.64,29.40,29.37,26.63,22.73,14.17.HRMS:m/z[M]+calcd for(C40H59NS):585.4362;found:585.4364. 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 8.07 (dd, 2H), 7.59 (s, 1H), 7.50 (dd, 1H), 7.45 (t, 1H), 7.40–7.37 (m, 2H) ), 7.30–7.29(m, 1H), 7.22(t, 1H), 7.12(dd, 1H), 4.18(d, 2H), 2.15(s, 1H), 1.38–1.21(m, 40H), 0.88( dd, 6H). 13 C NMR (100MHz, CDCl 3 ), δ (ppm): 145.79, 141.52, 141.32, 131.95, 128.05, 125.66, 124.47, 122.90, 122.61, 122.31, 120.61, 120.25, 118.936, 117.44 106.28, 47.62, 37.92, 31.94, 31.92, 29.98, 29.69, 29.64, 29.40, 29.37, 26.63, 22.73, 14.17. HRMS: m/z[M] + calcd for (C 40 H 59 NS): 585.4362; found: 585.4364 .
由上可知,该化合物结构正确,为所示中间体d。From the above, it can be seen that the compound has the correct structure and is the intermediate d shown.
(3)中间体e的合成:在氮气保护下,向250mL的三口瓶中加入4g中间体d(6.8mmol)、50mL的超干四氢呋喃溶剂。将溶液冷却至-78℃后,滴加正丁基锂的正己烷溶液(2.9mL,7.14mmol),并在-78℃下搅拌1.5h,升至室温搅拌30min后,将反应混合物再次冷却至-78℃。然后,一次性加入三丁基氯化锡(2.16mL,7.48mmol),升温至室温搅拌12小时后。二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,过滤,旋除溶剂,得到中间体e(5.4g,90%),未经提纯,直接用于下一步反应。(3) Synthesis of intermediate e: Under nitrogen protection, 4 g of intermediate d (6.8 mmol) and 50 mL of ultra-dry tetrahydrofuran solvent were added to a 250 mL three-necked flask. After cooling the solution to -78 °C, n-butyllithium in n-hexane solution (2.9 mL, 7.14 mmol) was added dropwise, and the solution was stirred at -78 °C for 1.5 h. After warming to room temperature and stirring for 30 min, the reaction mixture was cooled again to -78°C. Then, tributyltin chloride (2.16 mL, 7.48 mmol) was added in one portion, and the temperature was raised to room temperature and stirred for 12 hours. Extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, filtered, and spun off to remove the solvent to obtain intermediate e (5.4 g, 90%), which was directly used in the next reaction without purification.
(4)中间体a’和b’的合成:在氮气保护下,向两口瓶中加入300mg的7-溴-4-氯-[1,2,5]噻二唑-[3,4-c]吡啶(1.2mmol)、996mg的中间体e(1.2mmol)、双(三苯基膦)二氯化钯(0.01mmol)和15mL的甲苯溶剂。105℃下搅拌6小时后,冷却至室温。有机相用二氯甲烷和饱和食盐水萃取,分离有机相,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=4︰1,V︰V),得345mg的深红色固体即中间体a’(收率=36%),299mg亮红色固体即中间体b’(收率=33%)。(4) Synthesis of intermediates a' and b': under nitrogen protection, add 300 mg of 7-bromo-4-chloro-[1,2,5]thiadiazole-[3,4-c to a two-necked flask ]pyridine (1.2 mmol), 996 mg of intermediate e (1.2 mmol), bis(triphenylphosphine)palladium dichloride (0.01 mmol) and 15 mL of toluene solvent. After stirring at 105°C for 6 hours, it was cooled to room temperature. The organic phase was extracted with dichloromethane and saturated brine, the organic phase was separated, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel column (eluent: petroleum ether: dichloromethane = 4: 1, V: V), 345 mg of dark red solid was obtained as intermediate a' (yield = 36%), 299 mg of bright red solid was Intermediate b' (yield = 33%).
结构表征数据如下:The structural representation data is as follows:
中间体a’:1H NMR(400MHz,CDCl3),δ(ppm):8.71(d,1H),8.67(s,1H),8.10(t,2H),7.73(s,1H),7.62(dd,1H),7.56(d,1H),7.47(t,1H),7.39(d,1H),7.24(d,1H),4.20(d,2H),2.17(s,1H),1.39–1.20(m,40H),0.98–0.83(m,6H).13C NMR(100MHz,CDCl3),δ(ppm):156.30,151.49,147.91,147.32,145.81,141.60,141.24,139.35,134.14,131.00,126.06,124.83,123.23,122.45,120.73,120.38,119.16,117.22,109.13,107.75,106.43,47.68,37.86,31.92,31.87,29.98,29.68,29.63,29.36,26.60,22.68,14.12.HRMS:m/z[M]+calcdfor(C45H59BrN4S2):798.3359;found:798.3361.Intermediate a': 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 8.71 (d, 1H), 8.67 (s, 1H), 8.10 (t, 2H), 7.73 (s, 1H), 7.62 ( dd, 1H), 7.56(d, 1H), 7.47(t, 1H), 7.39(d, 1H), 7.24(d, 1H), 4.20(d, 2H), 2.17(s, 1H), 1.39–1.20 (m, 40H), 0.98–0.83 (m, 6H). 13 C NMR (100 MHz, CDCl 3 ), δ (ppm): 156.30, 151.49, 147.91, 147.32, 145.81, 141.60, 141.24, 139.35, 134.14, 131.00, 126.06,124.83,123.23,122.45,120.73,120.38,119.16,117.22,109.13,107.75,106.43,47.68,37.86,31.92,31.87,29.98,29.68,29.63,29.36,26.60,22.68,14.12.HRMS:m/z[ M] + calcdfor(C 45 H 59 BrN 4 S 2 ): 798.3359; found: 798.3361.
由上可知,该化合物结构正确,为所示中间体a’。From the above, it can be seen that the structure of this compound is correct, and it is the intermediate a' shown.
中间体b’:1H NMR(400MHz,CDCl3),δ(ppm):8.69(s,1H),8.18(d,1H),8.12–8.09(m,2H),7.68(s,1H),7.59(d,1H),7.52(d,1H),7.47(d,1H),7.40(d,1H),7.25(s,1H),4.22(d,2H),2.17(s,1H),1.40–1.20(m,40H),0.85(dd,6H).13C NMR(100MHz,CDCl3),δ(ppm):154.75,149.04,148.85,148.51,142.93,141.61,141.25,138.98,133.76,130.99,130.25,125.99,124.05,122.99,122.47,120.76,120.36,119.15,117.28,109.12,106.21,47.62,37.92,31.90,29.97,29.64,29.35,29.33,26.62,22.68,14.12.HRMS:m/z[M]+calcd for(C45H59ClN4S2):754.3864;found:754.3863.Intermediate b': 1 H NMR (400 MHz, CDCl 3 ), δ (ppm): 8.69 (s, 1H), 8.18 (d, 1H), 8.12-8.09 (m, 2H), 7.68 (s, 1H), 7.59(d,1H),7.52(d,1H),7.47(d,1H),7.40(d,1H),7.25(s,1H),4.22(d,2H),2.17(s,1H),1.40 -1.20 (m, 40H), 0.85 (dd, 6H). 13 C NMR (100 MHz, CDCl 3 ), δ (ppm): 154.75, 149.04, 148.85, 148.51, 142.93, 141.61, 141.25, 138.98, 133.76, 130.99, 130.25,125.99,124.05,122.99,122.47,120.76,120.36,119.15,117.28,109.12,106.21,47.62,37.92,31.90,29.97,29.64,29.35,22.3,14.68HRMS, + calcd for (C 45 H 59 ClN 4 S 2 ): 754.3864; found: 754.3863.
由上可知,该化合物结构正确,为所示中间体b’。From the above, it can be seen that the structure of this compound is correct, and it is the intermediate b' shown.
(5)目标产物M4的合成:在氮气保护下,向两口瓶中加入230mg的中间体a’(0.29mmol)、75.5mg的联硼酸频那醇酯(0.29mmol)、88mg的醋酸钾(0.87mmol)、双(三苯基膦)二氯化钯(0.03mmol)和8mL的1,4-二氧六环溶剂。80℃下搅拌8个小时后,采用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=4︰1,V︰V),得到176mg紫黑色固体即目标产物M4(收率=85%)。(5) Synthesis of target product M4: under nitrogen protection, 230 mg of intermediate a' (0.29 mmol), 75.5 mg of biboronic acid pinacol ester (0.29 mmol), 88 mg of potassium acetate (0.87 mmol) were added to the two-necked flask mmol), bis(triphenylphosphine)palladium dichloride (0.03 mmol) and 8 mL of 1,4-dioxane solvent. After stirring at 80° C. for 8 hours, extract with dichloromethane and saturated brine, dry over anhydrous magnesium sulfate, and spin dry the solvent to obtain a crude product. Purified by silica gel chromatography (eluent: petroleum ether: dichloromethane = 4: 1, V: V) to obtain 176 mg of purple-black solid, the target product M4 (yield = 85%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.55(s,2H),8.56(d,2H),8.04(t,4H),7.62(s,2H),7.54(d,2H),7.43–7.41(m,4H),7.32(d,2H),7.21(t,2H),4.12(d,4H),2.13(s,2H),1.39–1.21(m,80H),0.85(td,12H).13C NMR(100MHz,CDCl3),δ(ppm):155.94,151.23,148.16,147.54,146.08,141.61,141.22,140.24,134.01,131.11,125.99,124.77,123.13,122.50,120.63,120.37,119.67,119.11,117.22,109.15,106.30,47.70,37.89,31.93,30.01,29.66,29.64,29.37,29.36,26.64,22.69,14.13.HRMS:m/z[M]+calcd for(C90H118N8S4):1438.8356;found:1438.8368. 1 H NMR (400MHz, CDCl 3 ), δ(ppm): 9.55(s, 2H), 8.56(d, 2H), 8.04(t, 4H), 7.62(s, 2H), 7.54(d, 2H), 7.43–7.41(m, 4H), 7.32(d, 2H), 7.21(t, 2H), 4.12(d, 4H), 2.13(s, 2H), 1.39–1.21(m, 80H), 0.85(td, 12H). 13 C NMR (100MHz, CDCl 3 ), δ (ppm): 155.94, 151.23, 148.16, 147.54, 146.08, 141.61, 141.22, 140.24, 134.01, 131.11, 125.99, 124.77, 123.13, 120.77, 123.13, 120.650 119.67,119.11,117.22,109.15,106.30,47.70,37.89,31.93,30.01,29.66,29.64,29.37,29.36,26.64,22.69,14.13.HRMS :m/z[M] + calcd for(C 90 H 118 S4): 1438.8356 ; found: 1438.8368.
由上可知,该化合物结构正确,为所示目标产物M4。It can be seen from the above that the structure of this compound is correct, and it is the target product M4 shown.
实施例5:Example 5:
一种本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记为M5,具有式(II)的结构通式:An organic small molecule conjugated material containing an isotactic bipyridine thiadiazole acceptor of the present invention, denoted as M5, has the general structural formula of formula (II):
其中,Ar为R2为2-癸基十四烷基。Among them, Ar is R 2 is 2-decyltetradecyl.
M5具体的结构式为:The specific structural formula of M5 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M5的合成路线为:A synthetic route of the organic small molecule conjugated material M5 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
步骤(1)、(2)、(3)的合成方法同实施例4。The synthetic methods of steps (1), (2) and (3) are the same as in Example 4.
(4)目标产物M5的合成:在氮气保护下,向两口瓶中加入200mg的中间体b’(0.26mmol)、57.8mg的1,1,1,2,2,2-六甲基二锡(0.18mmol)、双(三苯基膦)二氯化钯(0.03mmol)和7mL的甲苯溶剂。110℃下搅拌24小时后,取有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=1︰1,V︰V),得76.2mg紫色固体即目标产物M5(收率=40%)。(4) Synthesis of target product M5: under nitrogen protection, add 200 mg of intermediate b' (0.26 mmol) and 57.8 mg of 1,1,1,2,2,2-hexamethyldistin to a two-necked flask (0.18 mmol), bis(triphenylphosphine)palladium dichloride (0.03 mmol) and 7 mL of toluene solvent. After stirring at 110°C for 24 hours, the organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel chromatography (eluent: petroleum ether: dichloromethane = 1: 1, V: V) to obtain 76.2 mg of purple solid, the target product M5 (yield = 40%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.30(s,2H),8.33(d,2H),8.11(t,4H),7.71(s,2H),7.62(d,2H),7.57(d,2H),7.48(t,2H),7.40(d,2H),7.27(s,0.33H),7.24(d,0.66H),4.23(d,4H),2.19(s,2H),1.42–1.21(m,80H),0.85(td,12H).13C NMR(100MHz,CDCl3),δ(ppm):154.94,150.04,149.25,147.67,141.64,141.24,139.87,134.87,131.09,130.76,125.97,124.22,123.10,123.02,122.51,120.72,120.38,119.12,117.38,109.13,106.18,47.65,37.96,31.92,29.99,29.68,29.65,29.62,29.36,29.34,26.63,22.68,14.12.HRMS:m/z[M]+calcd for(C90H118N8S4):1439.8435;found:1439.8441. 1 H NMR (400MHz, CDCl 3 ), δ(ppm): 9.30(s, 2H), 8.33(d, 2H), 8.11(t, 4H), 7.71(s, 2H), 7.62(d, 2H), 7.57(d, 2H), 7.48(t, 2H), 7.40(d, 2H), 7.27(s, 0.33H), 7.24(d, 0.66H), 4.23(d, 4H), 2.19(s, 2H) , 1.42–1.21 (m, 80H), 0.85 (td, 12H). 13 C NMR (100MHz, CDCl 3 ), δ (ppm): 154.94, 150.04, 149.25, 147.67, 141.64, 141.24, 139.87, 134.87, 131.09, 130.76,125.97,124.22,123.10,123.02,122.51,120.72,120.38,119.12,117.38,109.13,106.18,47.65,37.96,31.92,29.99,29.68,29.65,29.62,29.36,29.34,26.63,22.68,14.12.HRMS: m/z[M] + calcd for (C 90 H 118 N 8 S 4 ): 1439.8435; found: 1439.8441.
由上可知,该化合物结构正确,为所示目标产物M5。It can be seen from the above that the structure of this compound is correct, and it is the target product M5 shown.
实施例6:Example 6:
一类本发明的含等规双吡啶噻二唑受体的有机小分子共轭材料,记为M6,具有式(III)的结构通式:A class of organic small molecule conjugated materials containing isotactic bipyridine thiadiazole acceptors of the present invention, denoted as M6, has the general structural formula of formula (III):
其中,Ar为R2为2-癸基十四烷基。Among them, Ar is R 2 is 2-decyltetradecyl.
M6具体的结构式为:The specific structural formula of M6 is:
一种本实施例的含等规双吡啶噻二唑受体的有机小分子共轭材料M6的合成路线为:A synthetic route of the organic small molecule conjugated material M6 containing isotactic bipyridine thiadiazole acceptors of the present embodiment is:
步骤(1)、(2)、(3)的合成方法同实施例4。The synthetic methods of steps (1), (2) and (3) are the same as in Example 4.
(4)目标产物M6的合成:在氮气保护下,向两口瓶中加入100mg的中间体b’(0.13mmol)、55.7mg的1,1,1,2,2,2-六甲基二锡(0.17mmol)、双(三苯基膦)二氯化钯(0.01mmol)和8mL的甲苯溶剂,在110℃下搅拌1小时后,再一次性加入106mg的中间体a’(0.13mmol),继续在110℃下搅拌24小时后,取有机相用二氯甲烷和饱和食盐水萃取,无水硫酸镁干燥,旋干溶剂得粗产品。采用硅胶色谱柱提纯(洗脱剂为石油醚︰二氯甲烷=1︰1,V︰V),得89.3mg深紫色固体即目标产物M6(收率=47%)。(4) Synthesis of target product M6: under nitrogen protection, add 100 mg of intermediate b' (0.13 mmol) and 55.7 mg of 1,1,1,2,2,2-hexamethyldistin to a two-necked flask (0.17 mmol), bis(triphenylphosphine) palladium dichloride (0.01 mmol) and 8 mL of toluene solvent, after stirring at 110 ° C for 1 hour, 106 mg of intermediate a' (0.13 mmol) was added at one time, After continuing to stir at 110° C. for 24 hours, the organic phase was extracted with dichloromethane and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was spin-dried to obtain a crude product. Purified by silica gel column (eluent: petroleum ether:dichloromethane=1:1, V:V) to obtain 89.3 mg of dark purple solid, the target product M6 (yield=47%).
结构表征数据如下:The structural representation data is as follows:
1H NMR(400MHz,CDCl3),δ(ppm):9.61(s,1H),9.24(s,1H),8.83(d,1H),8.24(d,1H),8.10(t,4H),7.75(s,1H),7.68–7.63(m,2H),7.60–7.58(m,2H),7.52(d,1H),7.47(t,2H),7.39(d,2H),7.24(d,2H),4.20(d,4H),2.18(s,2H),1.41–1.21(m,80H),0.85(td,12H).13C NMR(100MHz,CDCl3),δ(ppm):157.40,155.08,153.77,151.63,149.75,148.61,148.54,148.27,148.17,147.86,147.32,141.57,141.17,140.39,140.12,135.01,134.75,131.07,131.00,129.93,126.08,125.86,125.79,124.84,123.99,123.17,122.84,122.48,121.62,121.47,120.70,120.60,120.38,120.31,119.12,119.06,117.33,117.26,117.19,109.13,106.38,106.08,47.67,37.96,37.88,31.93,30.01,29.67,29.64,29.37,29.36,26.64,22.69,14.13.HRMS:m/z[M]+calcd for(C90H118N8S4):1438.8356;found:1438.8361. 1 H NMR (400MHz, CDCl 3 ), δ(ppm): 9.61(s, 1H), 9.24(s, 1H), 8.83(d, 1H), 8.24(d, 1H), 8.10(t, 4H), 7.75(s, 1H), 7.68–7.63(m, 2H), 7.60–7.58(m, 2H), 7.52(d, 1H), 7.47(t, 2H), 7.39(d, 2H), 7.24(d, 2H), 4.20(d, 4H), 2.18(s, 2H), 1.41–1.21(m, 80H), 0.85(td, 12H). 13 C NMR (100MHz, CDCl 3 ), δ(ppm): 157.40, 155.08,153.77,151.63,149.75,148.61,148.54,148.27,148.17,147.86,147.32,141.57,141.17,140.39,140.12,135.01,134.75,131.07,131.00,129.93,126.08,125.86,125.79,124.84,123.99,123.17, 122.84,122.48,121.62,121.47,120.70,120.60,120.38,120.31,119.12,119.06,117.33,117.26,117.19,109.13,106.38,106.08,47.67,37.96,37.88,31.93,30.01,29.67,29.64,29.37,29.36, 26.64, 22.69, 14.13. HRMS: m/z[M] + calcd for (C 90 H 118 N 8 S 4 ): 1438.8356; found: 1438.8361.
由上可知,该化合物结构正确,为所示目标产物M6。It can be seen from the above that the structure of this compound is correct, and it is the target product M6 shown.
测试1:Test 1:
对实施例1~6中目标产物M1、M2、M3、M4、M5、M6进行结构规整性的测定:The structural regularity of the target products M1, M2, M3, M4, M5, and M6 in Examples 1 to 6 was determined:
图1和图2为M1的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.37ppm)和相邻噻吩上的质子(δ=8.60ppm)之间没发现任何关联峰,因而证实了目标产物M1的结构规整性正确;Fig. 1 and Fig. 2 are the 1 H- 1 H NOE spectra of M1 when the mixing time is 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.37ppm) and the protons on the adjacent thiophene (δ=9.37ppm) = 8.60 ppm) without any correlation peak, thus confirming that the structural regularity of the target product M1 is correct;
图3和图4为M2的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.16ppm)和相邻噻吩上的质子(δ=8.12ppm)之间没发现任何关联峰,因而证实了目标产物M2的结构规整性正确;Fig. 3 and Fig. 4 are the 1 H- 1 H NOE spectra of M2 when the mixing time is 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.16ppm) and the protons on the adjacent thiophene (δ=9.16ppm) = 8.12ppm), no correlation peak was found, thus confirming that the structural regularity of the target product M2 is correct;
图5和图6为M3的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.49/9.13ppm)和相邻噻吩上的质子(δ=8.68/8.05ppm)之间没发现任何关联峰,因而证实了目标产物M3的结构规整性正确;Fig. 5 and Fig. 6 are the 1 H- 1 H NOE spectra of M3 when the mixing time is 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.49/9.13ppm) and the protons on the adjacent thiophene (δ=8.68/8.05ppm) did not find any correlation peak, thus confirming that the structural regularity of the target product M3 is correct;
图7和图8为M4的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.66ppm)和相邻噻吩上的质子(δ=8.56ppm)之间没发现任何关联峰,因而证实了目标产物M4的结构规整性正确;Figures 7 and 8 are the 1 H- 1 H NOE spectra of M4 when the mixing time is 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.66ppm) and the protons on the adjacent thiophene (δ=9.66ppm) = 8.56ppm) without any correlation peak, thus confirming that the structural regularity of the target product M4 is correct;
图9和图10为M5的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.30ppm)和相邻噻吩上的质子(δ=8.34ppm)之间没发现任何关联峰,因而证实了目标产物M5的结构规整性正确;Figures 9 and 10 show the 1 H- 1 H NOE spectra of M5 with mixing time of 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.30ppm) and the protons on the adjacent thiophene (δ=9.30ppm) = 8.34ppm), no correlation peak was found, thus confirming that the structural regularity of the target product M5 is correct;
图11和图12为M6的混合时间分别为0.3s和0.8s的1H-1H NOE谱图,由图可知,PT上的质子(δ=9.61/9.24ppm)和相邻噻吩上的质子(δ=8.83/8.25ppm)之间没发现任何关联峰,因而证实了目标产物M6的结构规整性正确。Figures 11 and 12 are the 1 H- 1 H NOE spectra of M6 with mixing time of 0.3s and 0.8s, respectively. It can be seen from the figures that the protons on PT (δ=9.61/9.24ppm) and the protons on the adjacent thiophene (δ=8.83/8.25ppm), no correlation peak was found, thus confirming that the structural regularity of the target product M6 is correct.
测试2:Test 2:
对目标产物M1、M2和M3进行吸收光谱性质的测定:图13为目标产物M1、M2和M3在三氯甲烷溶液中的紫外–可见–近红外吸收光谱;图14为目标产物M1、M2和M3在石英片上薄膜的紫外–可见–近红外吸收光谱。在三氯甲烷溶液中,目标产物M1、M2和M3展现出的光谱吸收范围分别为250~642nm、250~649nm和250~656nm,其薄膜吸收最大吸收边带值分别为642nm、649nm和656nm。目标产物M1、M2和M3相应的光学带隙分别为1.93eV、1.91eV和1.89eV(光学带隙根据公式Eg=1240/λ计算,其中Eg为光学带隙,λ为薄膜吸收最大吸收边带值)。Determination of the absorption spectrum properties of the target products M1, M2 and M3: Figure 13 shows the UV-Vis-NIR absorption spectra of the target products M1, M2 and M3 in chloroform solution; Figure 14 shows the target products M1, M2 and Ultraviolet–visible–near-infrared absorption spectra of M3 films on quartz plates. In the chloroform solution, the target products M1, M2 and M3 exhibited spectral absorption ranges of 250-642 nm, 250-649 nm and 250-656 nm, respectively, and their film absorption maximum absorption sideband values were 642 nm, 649 nm and 656 nm, respectively. The corresponding optical band gaps of the target products M1, M2 and M3 are 1.93 eV, 1.91 eV and 1.89 eV respectively (the optical band gap is calculated according to the formula E g = 1240/λ, where E g is the optical band gap and λ is the absorption maximum absorption of the film. sideband value).
测试3:Test 3:
对目标产物M4、M5和M6进行吸收光谱性质的测定:图15为目标产物M4~M6在三氯甲烷溶液中的紫外–可见–近红外吸收光谱;图16为目标产物M4~M6在石英片上薄膜的紫外–可见–近红外吸收光谱。在三氯甲烷溶液中,目标产物M4、M5和M6展现出的光谱吸收范围分别为300~699nm、300~686nm和300~690nm,其薄膜吸收最大吸收边带值分别为699nm、686nm和690nm。目标产物M4、M5和M6相应的光学带隙分别为1.77eV、1.81eV和1.80eV(光学带隙根据公式Eg=1240/λ计算,其中Eg为光学带隙,λ为薄膜吸收最大吸收边带值)。Determination of the absorption spectrum properties of the target products M4, M5 and M6: Figure 15 shows the UV-Vis-NIR absorption spectra of the target products M4-M6 in chloroform solution; Figure 16 shows the target products M4-M6 on a quartz plate UV-Vis-NIR absorption spectra of thin films. In the chloroform solution, the target products M4, M5 and M6 exhibited spectral absorption ranges of 300-699 nm, 300-686 nm and 300-690 nm, respectively, and their thin-film absorption maximum absorption sideband values were 699 nm, 686 nm and 690 nm, respectively. The corresponding optical band gaps of the target products M4, M5 and M6 are 1.77 eV, 1.81 eV and 1.80 eV respectively (the optical band gap is calculated according to the formula E g = 1240/λ, where E g is the optical band gap and λ is the absorption maximum absorption of the film. sideband value).
测试4:Test 4:
对实施例1~实施例6中目标产物M1、M2、M3、M4、M5和M6进行摩尔消光系数的测定:图17为目标产物M1、M2和M3在三氯溶液(C=1×10-5M)中的摩尔消光系数谱图;图18为目标产物M4、M5和M6在三氯溶液(C=1×10-5M)中的摩尔消光系数谱图。由图可知,M1、M2和M3在最大吸收波长处的摩尔消光系数分别为3.13×104M-1cm-1、2.89×104M-1cm-1和3.04×104M- 1cm-1,M4、M5和M6在最大吸收波长处的摩尔消光系数分别为6.58×104M-1cm-1、4.90×104M- 1cm-1和5.93×104M-1cm-1;发现目标产物M4、M5和M6的摩尔消光系数值是M1、M2和M3的一倍。The molar extinction coefficients were measured for the target products M1, M2, M3, M4, M5 and M6 in Examples 1 to 6: Figure 17 shows the target products M1, M2 and M3 in trichloric solution (C=1×10 − 5 M) in the molar extinction coefficient spectrum; Figure 18 is the molar extinction coefficient spectrum of the target products M4, M5 and M6 in trichloride solution (C=1×10 -5 M). It can be seen from the figure that the molar extinction coefficients of M1, M2 and M3 at the maximum absorption wavelength are 3.13×10 4 M -1 cm -1 , 2.89×10 4 M -1 cm -1 and 3.04×10 4 M -1 cm -1 , respectively -1 , M4, M5 and M6 have molar extinction coefficients of 6.58×10 4 M -1 cm -1 , 4.90×10 4 M - 1 cm -1 and 5.93×10 4 M -1 cm -1 at the maximum absorption wavelength , respectively 1 ; It was found that the molar extinction coefficient values of the target products M4, M5 and M6 were twice that of M1, M2 and M3.
测试5:Test 5:
对实施例1~实施6中目标产物M1、M2、M3、M4、M5和M6进行荧光光谱的测定:图19为目标产物M1、M2和M3在三氯溶液中的荧光光谱图;图20分别为目标产物M4、M5和M6在三氯溶液中的荧光光谱图。由图可知,M1、M2和M3的最大发射波长分别为615nm、621nm和631nm;M4、M5和M6的最大发射波长分别为670nm、707nm和690nm。Measure the fluorescence spectra of the target products M1, M2, M3, M4, M5 and M6 in Examples 1 to 6: Figure 19 is the fluorescence spectra of the target products M1, M2 and M3 in trichloride solution; Figure 20 respectively Fluorescence spectra of target products M4, M5 and M6 in trichloride solution. It can be seen from the figure that the maximum emission wavelengths of M1, M2 and M3 are 615nm, 621nm and 631nm respectively; the maximum emission wavelengths of M4, M5 and M6 are 670nm, 707nm and 690nm respectively.
测试6:Test 6:
对实施例1~实施6中目标产物M1、M2、M3、M4、M5和M6进行电化学性质测定:图21为目标产物M1、M2和M3在三氯甲烷溶液中的循环伏安曲线;图22为目标产物M4、M5和M6在三氯甲烷溶液中的循环伏安曲线。测试条件为:采用三电极工作体系测定氧化还原电位,选取玻璃碳电极作为工作电极,Ag/AgCl为参比电极,铂丝电极作为对电极,浓度为0.1mol/L的四丁基六氟磷酸铵的三氯甲烷溶液作为支持电解质,二茂铁作为内标(0.38V vs.Ag/AgCl),扫描速率为100mV/s。由图21可知,M1、M2和M3的HOMO和LUMO能级分别为–5.19eV/–3.57eV,–5.21eV/–3.69eV和–5.20eV/–3.61eV;由图22可知,M4、M5和M6的HOMO和LUMO能级分别为–5.25eV/–3.62eV,–5.23eV/–3.75eV和–5.24eV/–3.67eV。The electrochemical properties of the target products M1, M2, M3, M4, M5 and M6 in Examples 1 to 6 were measured: Figure 21 is the cyclic voltammetry curves of the target products M1, M2 and M3 in chloroform solution; Figure 2 22 is the cyclic voltammetry curves of target products M4, M5 and M6 in chloroform solution. The test conditions are as follows: the three-electrode working system is used to measure the redox potential, the glassy carbon electrode is selected as the working electrode, the Ag/AgCl is used as the reference electrode, the platinum wire electrode is used as the counter electrode, and the concentration of tetrabutylhexafluorophosphoric acid is 0.1mol/L. Ammonium in chloroform was used as the supporting electrolyte, ferrocene was used as the internal standard (0.38 V vs. Ag/AgCl), and the scan rate was 100 mV/s. It can be seen from Figure 21 that the HOMO and LUMO energy levels of M1, M2 and M3 are –5.19eV/–3.57eV, –5.21eV/–3.69eV and –5.20eV/–3.61eV respectively; it can be seen from Figure 22 that M4, M5 The HOMO and LUMO levels of M6 and M6 are –5.25eV/–3.62eV, –5.23eV/–3.75eV and –5.24eV/–3.67eV, respectively.
实施例7:Example 7:
一种实施例4中以含等规双吡啶噻二唑受体的有机小分子共轭材料M4在制备顶栅底接触FET器件中的应用,其顶栅底接触FET器件的结构示意图如图23所示,其应用方法为:An application of the organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor in the preparation of a top-gate bottom-contact FET device in Example 4, the schematic structural diagram of the top-gate bottom-contact FET device is shown in Figure 23 As shown, its application method is:
(1)采用玻璃作为衬底,金源/漏电极由30nm的金和5nm的钛组成,FET器件的沟道宽度(W)和沟道长度(L)分别为1400μm和5μm;(1) Using glass as the substrate, the gold source/drain electrodes are composed of 30nm gold and 5nm titanium, and the channel width (W) and channel length (L) of the FET device are 1400μm and 5μm, respectively;
(2)在氮气箱中,将有机半导体材料M4配制成浓度为10mg/mL的二氯苯溶液,然后在玻璃衬底表面旋涂一层厚度为40nm的半导体活性层薄膜,最后将薄膜样品置于120℃的热台上退火10min;(2) In a nitrogen box, the organic semiconductor material M4 was prepared into a dichlorobenzene solution with a concentration of 10 mg/mL, and then a semiconductor active layer film with a thickness of 40 nm was spin-coated on the surface of the glass substrate, and finally the film sample was placed Annealed on a hot stage at 120°C for 10min;
(3)随后,通过旋涂60mg/mL的聚甲基丙烯酸甲酯(PMMA)的醋酸丁酯溶液,在半导体层表面形成一层厚度约900nm的PMMA介电层薄膜。为了除去介电层中的醋酸丁酯溶剂,将整个器件置于80℃的真空干燥箱中烘烤30分钟;(3) Subsequently, a PMMA dielectric layer film with a thickness of about 900 nm was formed on the surface of the semiconductor layer by spin coating a 60 mg/mL solution of polymethyl methacrylate (PMMA) in butyl acetate. In order to remove the butyl acetate solvent in the dielectric layer, the whole device was baked in a vacuum drying oven at 80°C for 30 minutes;
(4)最后,在PMMA介电层上蒸镀一层厚度约100nm的铝做为栅电极;(4) Finally, a layer of aluminum with a thickness of about 100 nm is vapor-deposited on the PMMA dielectric layer as the gate electrode;
在20~40%的空气湿度下,采用Keithley 4200SCS半导体测试仪测量了器件的半导体特性。其中,器件饱和区的空穴和电子迁移率由以下方程算出:IDS=(W/2L)Ciμ(VG–VT)2(饱和区,VDS=VG–VT)。其中,IDS为漏极电流,μ为载流子迁移率,VG为栅极电压,VT为阈值电压,Ci为绝缘体电容。The semiconductor characteristics of the device were measured with a Keithley 4200SCS semiconductor tester under 20-40% air humidity. The hole and electron mobilities in the device saturation region are calculated from the following equation: I DS =(W/2L)C i μ(V G −V T ) 2 (saturation region, V DS =V G −V T ). where I DS is the drain current, μ is the carrier mobility, V G is the gate voltage, V T is the threshold voltage, and C i is the insulator capacitance.
图24为本发明实施例4制备的以含等规双吡啶噻二唑受体的有机小分子共轭材料M4为有机活性半导体层的FET器件的输出特性曲线图。该曲线展现出很好的线性区和饱和区,说明基于有机半导体材料M4制备的FET器件具有良好的场效应调控性能。24 is a graph showing the output characteristics of the FET device prepared in Example 4 of the present invention, using the organic small molecule conjugated material M4 containing isotactic bipyridine thiadiazole acceptors as the organic active semiconductor layer. The curve shows a good linear region and saturation region, indicating that the FET device based on the organic semiconductor material M4 has good field effect control performance.
图25为采用本发明实施例4制备的以含等规双吡啶噻二唑受体的有机小分子共轭材料M4为有机活性半导体层的FET器件的转移特性曲线图。该器件展现出单极p-型传输器件性能,其空穴迁移率为0.05cm2/V s。FIG. 25 is a transfer characteristic curve diagram of a FET device using the organic small molecule conjugated material M4 containing an isotactic bipyridine thiadiazole acceptor as the organic active semiconductor layer prepared in Example 4 of the present invention. The device exhibits unipolar p-type transport device performance with a hole mobility of 0.05 cm 2 /V s.
以上研究结果表明:本发明提供了一种调控含双吡啶噻二唑受体单元的D-A型有机小分子共轭材料的结构规整调控方法,并提供了式(I)、式(II)和式(III)所示的含等规双吡啶噻二唑受体的有机小分子共轭材料。该类材料具有高的电子亲和力、大的共平面骨架、强的杂原子作用、结构规整的分子骨架和良好溶液加工性能等优势。本发明所提供的材料具有制备方法简单高效、原料易得以及推广性强等优势。通过改变不同的取代烷基链、杂原子取代、电子给体单元和吡啶氮原子的取代位置,可制备出系列的综合性能优异的含双受体单元的D-A型有机小分子共轭材料。The above research results show that the present invention provides a method for regulating the structure of D-A type organic small molecule conjugated materials containing bipyridine thiadiazole acceptor units, and provides formula (I), formula (II) and formula (III) The organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptors. Such materials have the advantages of high electron affinity, large coplanar framework, strong heteroatom interaction, structurally regular molecular framework, and good solution processability. The material provided by the invention has the advantages of simple and efficient preparation method, easy availability of raw materials and strong popularization. By changing the substitution positions of different substituted alkyl chains, heteroatom substitutions, electron donor units and pyridine nitrogen atoms, a series of D-A-type organic small molecule conjugated materials containing double acceptor units with excellent comprehensive properties can be prepared.
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制。虽然本发明已以较佳实施例揭示如上,然而并非用以限定本发明。任何熟悉本领域的技术人员,在不脱离本发明的精神实质和技术方案的情况下,都可利用上述揭示的方法和技术内容对本发明技术方案做出许多可能的变动和修饰,或修改为等同变化的等效实施例。因此,凡是未脱离本发明技术方案的内容,依据本发明的技术实质对以上实施例所做的任何简单修改、等同替换、等效变化及修饰,均仍属于本发明技术方案保护的范围内。The above descriptions are only preferred embodiments of the present invention, and do not limit the present invention in any form. Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Any person skilled in the art, without departing from the spirit and technical solutions of the present invention, can make many possible changes and modifications to the technical solutions of the present invention by using the methods and technical contents disclosed above, or modify them to be equivalent. Variant equivalent embodiments. Therefore, any simple modification, equivalent replacement, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention still fall within the protection scope of the technical solution of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010158042.3A CN111233898B (en) | 2020-03-09 | 2020-03-09 | A kind of organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010158042.3A CN111233898B (en) | 2020-03-09 | 2020-03-09 | A kind of organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111233898A true CN111233898A (en) | 2020-06-05 |
CN111233898B CN111233898B (en) | 2021-05-11 |
Family
ID=70878539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010158042.3A Active CN111233898B (en) | 2020-03-09 | 2020-03-09 | A kind of organic small molecule conjugated material containing isotactic bipyridine thiadiazole acceptor and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111233898B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12258441B1 (en) | 2024-05-24 | 2025-03-25 | Imam Mohammad Ibn Saud Islamic University | Fabrication of a conjugated polymer |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012174561A2 (en) * | 2011-06-17 | 2012-12-20 | The Regents Of The University Of California | REGIOREGULAR PYRIDAL[2,1,3]THIADIAZOLE π-CONJUGATED COPOLYMERS FOR ORGANIC SEMICONDUCTORS |
CN104321894A (en) * | 2012-03-23 | 2015-01-28 | 加利福尼亚大学董事会 | Inert solution-processable molecular chromophores for organic electronic devices |
CN107573489A (en) * | 2017-08-03 | 2018-01-12 | 湘潭大学 | A kind of polymer semiconductor containing double pyridine oxadiazole derivative acceptors and preparation method and application |
EP3339395A1 (en) * | 2014-08-01 | 2018-06-27 | Samsung Electronics Co., Ltd. | Condensed cyclic compound and organic light-emitting device including the same |
KR20180071882A (en) * | 2016-12-20 | 2018-06-28 | 주식회사 두산 | Organic compounds and organic electro luminescence device comprising the same |
CN109912631A (en) * | 2019-03-07 | 2019-06-21 | 西安理工大学 | Oligomeric thiophene derivatives using benzodithiophene and pyridothiadiazole as electron donating units respectively and preparation method thereof |
CN110105375A (en) * | 2019-05-30 | 2019-08-09 | 西安理工大学 | Give-by-to type Uniformpoly thiophene derivative and preparation method thereof to-by-using dithieno pyrroles as molecular center |
-
2020
- 2020-03-09 CN CN202010158042.3A patent/CN111233898B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012174561A2 (en) * | 2011-06-17 | 2012-12-20 | The Regents Of The University Of California | REGIOREGULAR PYRIDAL[2,1,3]THIADIAZOLE π-CONJUGATED COPOLYMERS FOR ORGANIC SEMICONDUCTORS |
CN104321894A (en) * | 2012-03-23 | 2015-01-28 | 加利福尼亚大学董事会 | Inert solution-processable molecular chromophores for organic electronic devices |
EP3339395A1 (en) * | 2014-08-01 | 2018-06-27 | Samsung Electronics Co., Ltd. | Condensed cyclic compound and organic light-emitting device including the same |
KR20180071882A (en) * | 2016-12-20 | 2018-06-28 | 주식회사 두산 | Organic compounds and organic electro luminescence device comprising the same |
CN107573489A (en) * | 2017-08-03 | 2018-01-12 | 湘潭大学 | A kind of polymer semiconductor containing double pyridine oxadiazole derivative acceptors and preparation method and application |
CN109912631A (en) * | 2019-03-07 | 2019-06-21 | 西安理工大学 | Oligomeric thiophene derivatives using benzodithiophene and pyridothiadiazole as electron donating units respectively and preparation method thereof |
CN110105375A (en) * | 2019-05-30 | 2019-08-09 | 西安理工大学 | Give-by-to type Uniformpoly thiophene derivative and preparation method thereof to-by-using dithieno pyrroles as molecular center |
Non-Patent Citations (6)
Title |
---|
CHIEN-MIN LIN,ET AL.: "Synthesis and enhanced electron transfer of supramolecular nano-composite containing dendritic dye and surface-modified ZnO nano-rods", 《DYES AND PIGMENTS》 * |
CHUNGUANG ZHU,ET AL.: "Regioregular Bis-Pyridal[2,1,3]thiadiazole-Based Semiconducting Polymer for High-Performance Ambipolar Transistors", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 * |
LEI YING,ET AL.: "Regioregular Pyridal[2,1,3]thiadiazole π-Conjugated Copolymers", 《JOURNAL OF THE AMERICAN CHEMICAL SOCIETY》 * |
PRASHANT SONAR,ET AL.: "Synthesis, characterization and comparative study of thiophene–benzothiadiazole based donor–acceptor-donor (D-A-D) materials", 《JOURNAL OF MATERIALS CHEMISTRY》 * |
SUMIT CHAURASIA,ET AL.: "Synthesis, optical and electrochemical properties", 《ORGANIC ELECTRONICS》 * |
黄薛龙: "新型共轭聚合物与齐聚物的设计合成与光电性能的研究", 《中国博士学位论文全文数据库 工程科技Ⅱ辑》 * |
Also Published As
Publication number | Publication date |
---|---|
CN111233898B (en) | 2021-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kozma et al. | Synthesis and characterization of new electron acceptor perylene diimide molecules for photovoltaic applications | |
CN110698498B (en) | Asymmetric fused ring benzotriazole receptor and preparation method and application thereof | |
CN103288848B (en) | Benzo three thiophenes and its production and use | |
CN108546267B (en) | Organic conjugated micromolecule material with terminal group containing cycloalkyl chain, preparation method thereof and application thereof in solar cell | |
CN110922569B (en) | Donor-receptor type ultralow band gap conjugated polymer based on imide pyrazine heterocycle and preparation method and application thereof | |
CN109096342B (en) | Pyrrolo-pyrrole-dione cyclic conjugated compound and preparation method and application thereof | |
CN113912627B (en) | Organic solar cell receptor material, preparation method thereof and organic solar cell | |
CN112047958B (en) | A kind of organic conjugated small molecule material containing thianthrene terminal group and its preparation method | |
CN109776566A (en) | A kind of A-D-A conjugated molecule based on polysubstituted benzocyclopentanedione derivatives and its application | |
CN104086561A (en) | Soluble organic photovoltaic micromolecule material with high fill factor, preparation method and application of material | |
WO2011047624A1 (en) | Sulfur containing heterocycle-fused naphthalene tetracarboxylic acid diimide derivatives, preparation method and use thereof | |
CN103664916B (en) | Conjugation small molecule material based on sub-two pyrroles of bithiophene and derivant thereof and preparation method and application | |
CN105968326B (en) | The preparation method of double pyrrolo-pyrrole-dione polymer and application | |
CN103304568B (en) | Trimerization Benzazole compounds and its production and use | |
CN103360397B (en) | Dithienyl pyrrolo-pyrrole-dione-naphthyl conjugate derivative and its preparation method and application | |
CN108192083B (en) | Conjugated polymer containing trifluoromethyl as well as preparation method and application thereof | |
CN111233898A (en) | Organic small molecule conjugated material containing isotactic bipyridine thiadiazole receptor and preparation method and application thereof | |
CN110872376B (en) | Cyclized indigo receptor and polymer as well as preparation method and application thereof | |
CN116375732B (en) | A non-fullerene acceptor material and its preparation method and application | |
CN108409755A (en) | A kind of organic photoelectric conversion material, preparation method and application | |
CN106750193A (en) | Even tripyrrole and pyrroledione polymer and its synthetic method and application | |
CN114479019B (en) | Triazine polymer material, preparation method thereof and application thereof in photoelectric device | |
Yang et al. | Squaraine dyes containing diphenylamine group: effects of different type structures on material properties and organic photovoltaic performances | |
CN109880065B (en) | Conjugated polymer containing trifluoromethyl group and its preparation method and application | |
CN110229148B (en) | A-D-A-D-A type organic small molecule solar cell donor material and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |